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The typical prenatal male or female development of the somatic sex is a complex 
differentiation process affected by multiple genes, enzymes and hormones. Conditions 
in which the development of the somatic sex is atypical are medically summarised under 
the umbrella term “Disorders of Sex Development“ (DSD) that was invented in 2005 by 
the „Chicago Consensus Group on management of intersex conditions“ - an international 
congress of experts. The Chicago Consensus Group defined DSD as congenital conditions 
with incongruence between chromosomal, gonadal and phenotypic sex (Lee, Houk, 
Ahmed, & Hughes, 2006). Along with the new terminology and classification the 
Chicago Consensus Group stated new clinical guidelines that emphasize the importance 
of psychosocial care: Because of the complexity of the conditions, counselling and 
treatment should be provided by multidisciplinary teams that include psychological 
expertise.  
In Germany the need for psychological support of persons with DSD and their families 
was confirmed by the German Ethical Committee in 2012, a statement of the German 
Medical Association in 2015 and new guidelines of the German Association of the 
Scientific Medical Societies (AWMF) published in 2016 (Deutscher Ethikrat, 2012; 
Stellungnahme der Bundesärztekammer, 2015). 
Yet knowledge about DSD is not adequately addressed in university studies ans 
postgraduate training in psychotherapy. Most research studies focus on medical aspects 
rather than on psychological or social aspects (Cohen-Kettenis, 2010; Schweizer, 
Brunner, Schützmann, Schonbucher, & Richter-Appelt, 2009). The two interdisciplinary 
multicentre studies network DSD and dsd-LIFE were initiated to close these research gap 
with a quantitative study design based on patient reported outcome and medical 
diagnoses. With the present cumulative thesis the request for psychosocial research will 
be addressed, a basis for implementing DSD care in education programme as it was 
required by the German Ethical Committee and others (Birnbaum et al., 2013; Cohen-
Kettenis, 2010; Deutscher Ethikrat, 2012; Richter-Appelt & Schweizer, 2010). 
In the following, first the typical prenatal sex development and DSD, then changes in 
clinical guidelines will be described. Subsequently the current research status, resulting 
in the research questions, will be presented. The methodical approach will be introduced 
followed by the three studies of the cumulative thesis. Finally, there is the general 
discussion which includes a review of the main findings, considerations on training of 
mental health professionals and the general conclusion of the thesis.  
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Prenatal somatic sex development  
Although the following description of the typical development of the somatic sex is 
simplified, it represents a basis to understand a variety of different DSD conditions.1 This 
medical background is important for psychosocial research, as DSD is a somatic 
condition and not a mental health problem.  
In the beginning there is no anatomical or gonadal sex in the embryo. Like all organs 
the reproductive system, the anatomical sex (internal and external sex characteristics) 
and the gonads (testis and ovaries) develop prenatally during pregnancy. The 
reproductive organs differentiate sex-dichotomous into male or female when different 
factors such as genetical information and hormones take effect. The foetal gonads, 
glands2 that are able to produces sex characteristic hormones, are able to differentiate 
into testis or ovaries (a so called bipotential gonad). They produce sex characteristic 
hormones such as androgens and oestrogens. These hormones exist in both sexes but 
differ in level. Within the typical prenatal sex development, the undifferentiated gonads 
develop into testes or ovaries depending on the karyotype of the foetus. The karyotype 
is usually either XY or XX, as prior to fertilisation the ovule contains a X sex chromosome 
and the spermatozoon and X or an Y sex chromosome.  
Consequently, three sexes can be distinguished: gonadal sex, anatomic sex and 
chromosomal sex.  
The chromosomal sex determines the sex development. The Y chromosome contains the 
sex determining region (SRY gen)3, which provides genetic information necessary for 
the development of the gonads into testes. If this information is missing, which usually 
is the case if there is an XX karyotype, the undifferentiated gonads will develop into 
ovaries.4 Similar to the gonadal sex the anatomic sex (internal and external sex organs) 
is undifferentiated in the foetus at first. All foetuses have Mullerian and Wolffian ducts 
- that can develop into female or male internal organs - and undifferentiated external 
organs. During typical sex development, the genital tubercle for instance will develop in 
phallus or clitoris. In typical male development with XY karyotype the gonads will 
develop into testes with Leydig cells which increasingly produce androgens effecting the 
development of the anatomic sex. The synthesis and action of androgens like 
testosterone and dihydrotestosterone (DHT) is complex, for different enzymes and 
receptors cells are needed. Androgens initiate a characteristic male development of the 
 
1 Parts of the description of the somatic basis have been published in German (Bennecke & Köhler, 2015) 
2 Other glands: thyroid gland, parathyroid, pancreas, pituitary gland, hypothalamus and adrenal glands. 
Along with the gonads the adrenal glands can produce androgens which can lead to a condition labelled as 
DSD (Congenital adrenal hyperplasia, CAH) 
3 SRY is known since the late 1980s. SRY directs the production of the protein responsible for the initiation 
of the testes development: testis determining factor (TDF). TDF stimulates cells to develop into Leydig cells. 
These testicular cells are able to produce androgens when stimulated. 
4 In addition to SRY numerous other genes are significant for gonadal development e.g. SOX9, DHH, TSPYL1 
or DAX1, WNT4, WT1, SF1 that influence SRY and WNT4, RSPO1 and FOXL2 that influence the 
development of ovaries (Rey & Grinspon, 2011). 
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external sex organs (androgenisation). Without androgenisation the external sex organs 
develop female phenotype. At the same time the internal sex organs differentiate into 
female or male characteristics. The development of the internal sex organs mainly 
depends on the influence of anti-Mullerian hormone (AMH). AMH is produced by Sertoli 
cells in the testes. In typical male development, there are high levels of AMH that supress 
the development of the Mullerian ducts so the Wolffian ducts can differentiate into male 
internal sex organs. If there is little AMH, the Mullerian ducts will develop into female  
internal sex organs and the Wolffian ducts do not differentiate (MacLaughlin & 
Donahoe, 2004).  
The development of the somatic sex therefore consists of three stages:  
a. the undifferentiated stage, when bipotential primitive structures develop 
independently of the chromosomal sex,  
b. gonadal differentiation into ovaries or testes that is initiated by sex characteristic 
genes,  
c. the differentiation of the anatomic sex (internal and external genitalia), which 
depends on the action of testicular hormones (Figure 1).  
If testicular hormones are absent the embryo will develop a female anatomic sex (Rey & 
Grinspon, 2011). As the foetal sex development is complex, variations of the typical two 
differentiation pathways occur naturally. In biology, there is no distinct cut-off between 
male and female; and neither the chromosomal sex, the gonadal sex nor the anatomic 
sex develop constantly as expected.  
Variations in sex development can be related to sex chromosomes, when e.g. ovule or 
sperm contain more than just one sex chromosome (XXY karyotype in Klinefelter 
syndrome) or one sex chromosome is missing partly or completely (X0 karyotype in 
Turner syndrome). In spite of a common set of sex chromosomes, other factors, e.g. a 
gene variation on SRY, can affect the development of the gonads, which then do not 
develop into fully functional testis or ovaries (gonadal dysgenesis). Gonadal variation 
influences their hormonal output, which can affect the development of the anatomic sex. 
Even though there is a typical XY karyotype, the adrenal steroidogenesis can be 
variegated due to absence of different enzymes. This can lead to low levels of testicular 
hormones such as testosterone and dihydrotestosterone (DHT) (in 5a-reductase 
deficiency and 17βHSD-3 enzyme deficiency). This can lead to little or no androgen 
effect on the anatomic sex. Even with high levels of androgens there can be little or no 
androgen effect, if there is a partial or complete absence of receptors for androgens 
(androgen insensitivity syndrome, AIS). Also, enzyme variations can lead to high levels 
of androgens produced in the adrenal gland, even when the chromosomal sex and 
gonadal development was typical for female development. This leads to a prenatal effect 




Figure 1: Prenatal sex development 














The spermatozoon contains an X or an Y 
chromosome. In addition to the autosome the ovule
contains an X chromosome. 
After fertilisation there are XX or XY sex
chromosomes (gonosomes). 
If there is an Y chromosome in the foetus, TDF will be
exposed later.
The undifferentiated gonads in the foetus can develop
in ovaries or testis. 
If there is TDF the gonads will develop to testes. If
there is no TDF ovaries will develop. 
Testis have cells producing AMH and testosterone. 
Testosterone can be transformed in DHT by enzymes.
Müllerian and wolfian ducs are present in all foetus. 
If there is a high level of AMH the müllerian ducs will 
be supressed and the wolfian ducs differentiate into
male internal sex organs (right). 
If there is little AMH the wolfian ducs do not 
differentiate and the müllerian duct will develop into
female internal sex organs (left). 
External sex organs are undifferentiated in foetus at
first.
If there is a hight level of DHT (and corresponding
receptors) the external genitalia will differentiate into
male. 




There are many different atypical pathways for prenatal sex developments and not all 
genetic reasons have been found, yet. Genetic variations can be found on manifold genes 
that determine proteins, enzymes or receptors and most of these genes are not located 
on the sex chromosomes. E.g. the gene for the enzyme 5α-reductases (SRD5A2) that 
converts testosterone in DHT is located on chromosome 2. In foetal development DHT 
is essential for androgenisation of the anatomic sex. Over 100 variations of this gene are 
known resulting in atypical sex development and still new variations are discovered 
constantly (Ittiwut et al., 2017).5 
The DSD classification proposed by the Chicago Consensus Group is summarising divers 
atypical sex developments (Lee et al., 2006). The new nomenclature was supposed to 
be a simple and logical classification of the causes of DSD (Hughes, 2008). Conditions 
were classified depending on the karyotype: Sex chromosome DSD, 46,XY DSD and 
46,XX DSD. Table 1 lists the DSD conditions. 
Table 1: DSD classification proposed by the Chicago Consensus Group  
Sex Chromosome DSD 46,XY DSD 46,XX DSD 
45,X (Turner syndrome and 
variants) 
Disorders of gonadal (testicular) 
development: (1) complete 
gonadal dysgenesis (Swyer 
syndrome); (2) partial 
gonadal dysgenesis; (3) 
gonadal regression; and (4) 
ovotesticular DSD 
Disorders of gonadal (ovarian) 
development: (1) 
ovotesticular DSD; (2) 
testicular DSD (e.g., SRY, 
duplicate SOX9); and (3) 
gonadal dysgenesis 
47,XXY (Klinefelter syndrome 
and variants) 
Disorders in androgen synthesis 
or action: (1) androgen 
biosynthesis defect (e.g., 17-
hydroxysteroid 
dehydrogenase deficiency, 
5_RD2 deficiency, StAR 
mutations); (2) defect in 
androgen action (e.g., CAIS, 
PAIS); (3) luteinizing 
hormone receptor defects 
(e.g., Leydig cell hypoplasia, 
aplasia); and (4) disorders 
of anti-Müllerian hormone 
and anti-Müllerian hormone 
receptor (persistent 
Müllerian duct syndrome) 





deficiency, POR [P450 
oxidoreductase]); and (3) 
maternal (luteoma, 
exogenous, etc) 





Other (e.g., cloacal exstrophy, 





Sex chromosome DSD has an incidence of 1:426, the most common conditions are 
Turner syndrome and Klinefelter syndrome (Nielsen & Wohlert, 1991). Even if only 
occurring in 1:2000-5000 individuals CAH is one of the most frequent DSD conditions 
(46, XX DSD) (Marumudi et al., 2013). Most other specific conditions, most of them 
classified as 46, XY DSD, have an incidence of 1:100.000 birth and less (Lux et al., 2009). 
 
5 As DHT is not necessary in female development, a variation of SRD5A2 in individuals with XX karyotype 
has no effect on the sex development. 
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All in all, approximately up to 1 of 200 individuals has an atypical prenatal sex 
development (Arboleda et al., 2013; Lee et al., 2016). 
The effects of an atypical sex development are very diverse, as are their causes. 
Particularly individuals, after whose birth the question "Is it a boy or a girl?" cannot be 
answered easily, are in the public discourse. Usually the anatomic sex is the basis for this 
first gender determination. In DSD the anatomic sex may have developed neither 
typically female nor typically male. These “ambiguous” genitals6 can cause a lot of 
confusion among parents as well as obstetricians. In this context often the term 
“intersexuality” is used. Other DSD conditions are associated with a typical female 
appearance of the external genitalia. Later in life for instance due to the absence of 
puberty, surprising androgenisation or other medical examinations (e.g. after a hernia) 
a DSD condition is discovered. 
Medical guidelines  
The change in medical care over the last decades is particularly significant in terms of 
variants of sex development, where there is both, "male" and "female" characteristics. 
Such developments have previously been labelled with the term "intersexuality" or 
"hermaphroditism". In these cases, the so-called "Optimal Gender Policy" had been the 
medical treatment guideline since the 1950s (Money, 1994; Money, Hampson, & 
Hampson, 1955). The fundament of the "Optimal Gender Policy" was the assumption 
that the development of a stable gender identity as a man or woman is of great 
importance for mental health. It was assumed that the (genital) appearance as a boy or 
girl was crucial for the development of a stable gender identity in childhood. It was also 
assumed that gender-based education promotes the development of a stable gender 
identity. Prenatal biological factors were viewed as less important for the development 
of gender identity.7 The "Optimal Gender Policy" therefore assumed, in accordance with 
the social perceptions of its time, that children are born neutral with regard to their 
gender and that a gender identity as a boy or girl is built up as a result of socialisation. 
In order to ensure the development of stable gender identity in children with 
"ambiguous" genitalia, it was recommended that the child’s anatomy should be surgically 
adjusted to one of the two sexes at an early stage. This usually led to feminisation of the 
external and internal genitalia. It was then recommended to the parents to raise the 
children according to the chosen gender. In the process, the children were not told about 
 
6 The term “ambiguous” is used in order to describe that the genital appearance cannot be classified in one 
of the two sex categories male or female. Nevertheless, these genitals are unambiguously genitals. The term 
“ambiguous” is therefore not accurate.  
7 The case study of David Reimer gained tragic fame. Born in 1965 the toddler "Bruce" lost his penis through 
an accident and was then assigned female and sex assignment surgery was performed at an early age 
(Money, 1975). In his childhood “Brenda” was not told about the natal sex (Bradley, Oliver, Chernick, & 
Zucker, 1998). In adolescents “Brenda” found out about the condition and thereupon he choose to live as a 
male, but unfortunately was not able to cope with his experiences and committed suicide in 2004. 
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their condition, since it was to be feared that this could destabilise the children (Bradley 
et al., 1998). 
The "Optimal Gender Policy" has been increasingly criticised within the last decades, 
especially by support groups and those affected. Treatment guidelines as well as patient 
rights have changed gradually. Since the early 1990s, the clinical care of individuals with 
DSD has developed into a holistic and patient-oriented approach in specialised teams 
(Roen & Pasterski, 2013). Changes of treatment recommendations were described by 
the Chicago Consensus Group, which met in 2005 (Lee et al., 2006). The Chicago 
Consensus statement also confirmed the importance of specialized interdisciplinary 
teams that include psychosocial care (Lee et al., 2006; Liao & Simmonds, 2013). In 
contrast to the traditional role of mental health specialists, psychological care in DSD is 
supposed to be an integral part of the care right from the start (Moran & Karkazis, 2012; 
Sandberg & Mazur, 2014). In Germany, the German Ethics Committee began to engage 
to the topic in 2010, followed by the new AWMF guidelines for "variants of sex 
development" and an statement of the German Medical Association (Deutscher Ethikrat, 
2012; Stellungnahme der Bundesärztekammer, 2015). In addition to the specialised 
interdisciplinary care, current treatment recommendations focus on informed consent. 
Informed consent means that children must be informed about their medical condition 
at an early stage and should participate in decisions about medical treatment. Current 
statements and guidelines have in common that they do not give a general treatment 
recommendation and refer to the heterogeneity of medical conditions. Surgical 
procedures, which are not a medical necessity, are discussed with regard to ethical and 
legal aspects. Current recommendations renounce from early surgical interventions in 
children with "ambiguous" genitalia, to which the "optimal gender policy" primarily 
referred.8 But still especially surgical interventions in individuals with CAH and XX 
karyotype and a high level of androgenisation are discussed controversially.  
Content of psychosocial research 
Psychosocial research in DSD is both, broad - as many different topics are taken into 
consideration – and limited, especially as most studies include only small sample sizes 
and medical condition of the study participants are diverse.  
Terminology 
The first issue when approaching DSD is its terminology. Even if the DSD terminology is 
widely accepted especially in medical research, it is not accepted by all clinicians and 
researchers. The new terminology of the Consensus Group resulted in criticism and was 
largely discussed right after its proposal (Clune-Taylor, 2010; Diamond & Beh, 2006; 
Feder, 2009; Feder & Karkazis, 2008; Guntram, 2013; Hughes, 2015; Hughes, Nihoul-
 
8 The topic “gender identity” has lost importance in current guidelines. Although “gender identity” is based 
on a bio-psycho-social explanatory model, nowadays the opinion that biological, mostly prenatal factors 
determine gender identity seems to spread. 
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Fékété, Thomas, & Cohen-Kettenis, 2007; Liao & Roen, 2013; Lin-Su, Lekarev, Poppas, 
& Vogiatzi, 2015; Pasterski, Prentice, & Hughes, 2010a; Simmonds, 2007). On the one 
hand the classification of some of the conditions under the umbrella term has been 
criticised. Some authors stated that CAH should not be included in the DSD classification 
(Gonzalez & Ludwikowski, 2016). Others proposed to exclude Klinefelter syndrome and 
Turner syndrome from the DSD classification, contrary to the inclusive approach of the 
consensus (Pasterski, Prentice, & Hughes, 2010b; Wit, Ranke, & Kelnar, 2007). 
Consequently, research about these three conditions rarely includes the DSD 
nomenclature. On the other hand, the nomenclature “Disorders of Sex Development” 
resulted in criticism. The term disorder was regarded as too pathologizing, failing to 
recognise that DSD could be considered as variants of normal and implying that all 
individuals with DSD are in need of fixing (Diamond & Beh, 2006; Reis, 2007). 
Consequently, alternative terms like Variations of Reproductive Development or Variations 
of Sex Development were proposed (Diamond & Beh, 2006; Simmonds, 2007). Some 
authors avoid the term disorder by using DSD as an acronym for Differences of Sex 
Development, Divergences of Sex Development or Diverse Sex Development (Arbeitsgruppe 
Ethik, 2008; Brunner et al., 2016; D'Alberton et al., 2015; Liao & Simmonds, 2013; Reis, 
2007; Schweizer, Brunner, Handford, & Richter-Appelt, 2013; Streuli, Köhler, Werner-
Rosen, & Mitchell, 2012; Streuli, Vayena, Cavicchia-Balmer, & Huber, 2013; Tamar-
Mattis, Baratz, Baratz Dalke, & Karkazis, 2013; Wiesemann, Ude-Koeller, Sinnecker, & 
Thyen, 2010). Moreover some authors decided to use the term “intersex”, some linked 
this term with the DSD acronym “intersex/DSD” and others refer to the phenotype of 
the anatomic sex by using „ambiguous genitalia”(Kraus, 2015; Lathrop, Cheney, & 
Hayman, 2014; Michala, Liao, Wood, Conway, & Creighton, 2014; Roen & Pasterski, 
2013). Despite the extensive discussions, which are held by support groups, empirical 
studies on the opinion of those affected are rare. There are four studies addressing this 
issue (Davies, Knight, Savage, Brown, & Malone, 2011; Davis, 2013; Guntram, 2013; 
Lin-Su et al., 2015). These studies include only small samples sizes with recruitment 
bias, as they were recruited mainly via support groups. Partly these studies refer to 
caregivers and not to individuals with DSD themselves. In one study the DSD condition 
of the participants remained unclear and in another individuals with conditions not 
classified as DSD were included. Furthermore, these studies show that there is equivocal 
opinion on the DSD terminology. So far there is no systematic evaluation of the opinion 
on the term DSD from a large sample of adults with different conditions classified as 
DSD. 
Quality of Life and psychological wellbeing 
Despite the controversy of the DSD classification, all DSD conditions have in common, 
that they are long-term physical conditions. Depending on the impact of androgens, the 
functional impairment of the gonads and the reproductive system, DSD can have 
different effects on the individual’s body and health. In general long-term physical health 
conditions are associated with higher levels of psychological problems compared to the 
general population (Liao & Simmonds, 2013). Often in psychosocial research Quality of 
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Life and psychological wellbeing are addressed, two indicators of successful adaptation 
to the condition. Until 1999, no studies adequately addressed Quality of Life for 
individuals with DSD (Meyer-Bahlburg, 1999; Schober, 1999b). Recently, an increasing 
number of psychologically oriented outcome studies assessing a wider range of 
psychosocial topics have been performed (Roen & Pasterski, 2013). Reviews on Quality 
of Life and psychological outcomes for adults with DSD cited nine original articles from 
1995 to 2004 and fifteen from 2005 to 2014 (Nordenstrom, 2015; Schützmann et al., 
2009; Wisniewski & Mazur, 2009; Zainuddin, Grover, Shamsuddin, & Mahdy, 2013). 
Although these studies address Quality of Life and psychological wellbeing of individuals 
with DSD, the results varied greatly. The studies are hardly comparable due to different 
diagnostic groups, heterogeneous samples, marked variations in overall quality, age 
groups and recruitment strategies. Often sample sizes are small. Additionally, it is 
difficult to compare the results directly due to many differences in the methodologies, 
but even in studies using the same method, the findings varied (Zainuddin et al., 2013). 
Consequently, the results are inconsistent and many findings cannot be generalised as 
almost all studies were limited by selection bias (Schützmann et al., 2009). It can be 
concluded that research about Quality of life and psychosocial outcomes in individuals 
with DSD are both scarce and inconsistent (Nordenstrom, 2015). All current reviews 
highlight the poor research status and conclude that all conditions are understudied 
(Wisniewski & Mazur, 2009).  
Psychological support for parents of children with DSD 
On one hand parents influence the wellbeing of their child, on the other they are most 
often addressees of the interdisciplinary DSD team when diagnosis is given in early 
childhood. Parents of children with other chronic conditions reported massive changes 
in daily life – a broken life world (Seiffge-Krenke, 2013). In addition to coping with the 
chronic condition of a child, the uncertainty, if a decision on the gender of rearing is 
needed, is especially likely to increase parental stress (Jürgensen, Hampel, Hiort, & 
Thyen, 2006). Gough, Weyman, Alderson, Butler, and Stoner (2008) highlighted the 
fundamental shock caused by the uncertain sex status of a child and documented 
parental struggles to negotiate a coherent gender identity for their children. There is a 
basic belief in a dichotomous sex in society and therefore in most parents; a profound 
conviction that a child is a boy or a girl (Lathrop et al., 2014; Sanders, Carter, & 
Goodacre, 2011). Atypical gender role behaviour and gender dysphoria in childhood and 
adolescence may foster confusion and stress in parents. It is likely that parents who 
experience caring, accepting and encouraging support are more prone to be able to 
develop these attitudes towards their child (Richter-Appelt, 2012). An atmosphere of 
uncertainty, fear and denial hampers positive development as described above (Richter-
Appelt, 2013). Psychological support could be a successful approach to help parents to 
cope with their child’s condition and foster positive family relationships. Therefore it has 
been recommended that interdisciplinary care of DSD should include a psychologist 
(Deutscher Ethikrat, 2012; Lee et al., 2006). It is assumed that appropriate counselling 
of parents and family starting at diagnosis is needed in order to achieve the best possible 
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development and quality of life for children and adolescents with DSD (Hiort, 2012; 
Moran & Karkazis, 2012). But yet it is unknown to what extent parents of children with 
DSD express their need for psychological support and if uncertainty of the sex, atypical 
gender behaviour or other factors influence this need.  
Other areas of psychosocial research 
Next to these fields of psychosocial research that will be addressed within the following 
research questions, psychosexual development and ethical considerations are often 
focussed in current research about DSD. In this thesis, it was chosen not to focus on 
these particular topics, as research about psychosexual development is frequent and does 
not primarily refer to clinical care. At the same time articles about ethical considerations 
most often make early sex assignment the subject of research, a topic only relevant for 
a minority of the DSD conditions. The acceptance of the DSD nomenclature, mental 
wellbeing and the need for psychological support of parents of children with DSD on the 
other hand, are closely linked to clinical care and relevant for most individuals with DSD. 
Nevertheless, research about psychosexual development and ethics is significant and was 
addressed within other sub studies of the two multicentre research studies that will be 
described after the specification of the research questions of this thesis.  
Research Questions 
Considering the gap in psychosocial research three research questions that are relevant 
for clinical DSD care were identified: 
1. Does the opinion of individuals with conditions classified as DSD about the DSD 
terminology conform with the dissatisfaction expressed by researchers, clinicians and 
support groups and should it be therefore avoided? 
2. How do individuals with different DSD conditions rate their Quality of Life and their 
psychological wellbeing, and how do diagnostic groups differ? 
3. Do parents of children with DSD express a need for psychological support and does 
gender and treatment related factors influence this need, so that psychological care 
for parents may focus on specific issues? 
Methodical approach 
The research questions were approached with two quantitative multicentre research 
studies. Details of the methods will be described within each of the sub studies 
addressing the research questions. Yet the two multicentre research studies network DSD 
and dsd-LIFE will be introduced shortly in the following.  
Network DSD 
The clinical evaluation study of the German network DSD funded by the German Federal 
Ministry of Education and Research (BMBF) investigated the clinical outcomes and 
health care situation of children, adolescents, and adults with DSD. It was the first 
multicentre outcome study in this field including individuals with DSD conditions 
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following the generic definition of a discrepancy of chromosomal, gonadal and 
phenotypical sex (excluding Klinefelter and Turner Syndromes) in German speaking 
countries. Network DSD was a large-scale clinical evaluation study on quality of life, 
gender identity, treatment satisfaction, coping, and problems associated with diagnoses 
and therapies in individuals with disorders of sex development (DSD). Recruitment took 
place at four study centres in Germany and at five sites in Austria and Switzerland 
between January 2005 and December 2007. A psychosocial inquiry of children, 
adolescents and adults with DSD and their parents was performed. All participants 
and/or their parents gave written informed consent for participation and release of 
medical data to the interviewer and the principal investigator. A total of 439 children 
and adolescents, their parents and adults with DSD participated. The study was 
described in detail by Lux et al. (2009).  
dsd-LIFE  
The European research group dsd-LIFE initiated a multicentre clinical evaluation study 
funded by the European Union Seventh Framework Programme (FP7/ 2007-2013). The 
study aimed to assess quality of life (QoL) as a measure of psychosocial adaptation, 
psychosexual and mental health aspects as major outcomes. Health status and 
functioning, medical and surgical therapies, participants’ views on health care, 
psychological and social support as well as sociodemographic factors were investigated. 
In addition, ethical considerations in the field of DSD were addressed and previous 
experiences with health care were gathered. Recruitment between 2014 and 2015 took 
place in 14 different medical centres in six countries: Poland, Sweden, Germany, France, 
United Kingdom and the Netherlands (Figure 2). Inclusion criteria of the study followed 
a generic definition of DSD as incongruence of the chromosomal, gonadal, and 
phenotypic sex with a laboratory-confirmed diagnosis or clinical diagnosis by a 
physician. The dsd-LIFE study comprised two parts: a) A medical interview, with blood 
tests, bone scans and a physical examinations and b) a patient reported outcome 
questionnaire consisting of standard questionnaires and questionnaires specifically 
developed for the purpose of this study. All participants gave written informed consent 
for the study. In total 1040 individuals with DSD participated in dsd-Life, making it the 
largest study with individuals with DSD worldwide to date. For details of the study 
design see Rohle et al. (2017). 
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Figure 2: Locations of project partners (Rohle et al., 2017) 
The following centres participated in the study: France: Université Claude Bernard 
Lyon; Le Centre Hospitalier Universitaire Montpellier; Université Paris-Sud, Paris; Le 
Centre Hospitalier Universitaire de Toulouse. Germany: Charité Universitätsmedizin 
Berlin; Ludwig-Maximilians-Universität, München; University of Lübeck; 
Universitätsmedizin Göttingen; Westfälische Wilhelms-Universität Münster. Poland: 
Medical University of Lodz; Children’s Memorial Health Institute, Warszawa. Sweden: 
Karolinska Institutet, Stockholm. United Kingdom: University of Birmingham. The 
Netherlands: VU University Medical Center, Amsterdam; Radboud University 
Nijmegen Medical Center, Nijmegen 
a physical examination, potentially augmented by further
examinations. Current and past treatment data were
obtained from a medical interview and medical chart
review. The wide age range of the subjects allowed assess-
ment and comparison of treatments that were typical in
certain decades but changed over time. PRO data came
mainly from an online survey, allowing privacy and
confidentiality for all participants. The design was chosen
to allow the analysis of associations of treatments and
interventions experienced in the past with contemporary
QoL, physical and mental health, psychosexual functioning
and satisfaction with care. In addition, we sought to exam-
ine participants’ views and perspectives on the ethics of
general health care and controversial treatments (Fig. 3).
We did not recruit a comparison or control group, but
results of major outcomes will be compared to reference
data. Moreover, we planned to use group comparisons of
the diagnoses within the sample because some issues
such as e.g. fertility or psychosexual problems are, to
varying degrees, issues for all people affected by DSD.
Instruments
The use of available, standardized instruments with ref-
erence data from the general population was preferred
whenever possible, thus allowing comparisons to the
general population, specifically in the areas of sociode-
mographics, QoL and screening measures of physical
and mental health, psychosexual outcome, psychological
factors and overall satisfaction with health care. For
specific aspects of DSD, we included “self-constructed”
items. The iterative review of the suggested instruments
and measurements was performed by experienced pa-
tient support group representatives and by the project’s
Advisory Board.
Fig. 2 Locations of project partners. The following centres participated in the study: France: Université Claude Bernard Lyon; Le Centre Hospitalier
Universitaire Montpellier; Université Paris-Sud, Paris; Le Centre Hospitalier Universitaire de Toulouse. Germany: Charité Universitätsmedizin Berlin;
Ludwig-Maximilians-Universität, München; University of Lübeck; Universitätsmedizin Göttingen; Westfälische Wilhelms-Universität Münster. Poland:
Medical University of Lodz; Children’s Memorial Health Institute, Warszawa. Sweden: Karolinska Inst tutet, Stockholm. United Kingdom: University
of Birmingham. The Netherlands: VU University Medical Center, Amsterdam; Radboud University Nijmegen Medical Center, Nijmegen
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Over a decade ago, the “Consensus Group on management of intersex condition” proposed 
Disorders of Sex Development (DSD) as umbrella term for “congenital conditions in which the 
development of chromosomal, gonadal, or anatomical sex is atypical”. The Group 
recommended the terminology be sensitive to concerns of individuals having these 
conditions. Yet, controversy rages over the term DSD. This multicentre clinical evaluation 
study was initiated as part of the European research group dsd-LIFE to evaluate patient-
reported outcome. In total, 1040 individuals with conditions labelled as Disorders of Sex 
Development were recruited in Poland, Sweden, Germany, France, United Kingdom and the 
Netherlands. All participants were asked to rate the terms describing their conditions. 
Overall, a large majority of participants (69%) reported that the term Disorders of Sex 
Development applies to their condition or that they feel neutral about it. Most participants 
preferred terms that were specific to their somatic condition. Overall, our data do not support 
the view that, in general, the term Disorders of Sex Development is insensitive to concerns of 
affected persons and that it should therefore be abandoned. However, in the clinical 
encounter, we recommend that clinicians evaluate each patient’s preferences. 
Introduction 
Over a decade ago the “International Consensus Conference on Intersex” in Chicago 
proposed Disorders of Sex Development and its acronym DSD as a new umbrella term for 
“congenital conditions in which the development of chromosomal, gonadal, or anatomical 
sex is atypical” (Lee et al., 2006). One goal of the Chicago Consensus issued in 2006 was to 
replace “particularly controversial terms” such as “intersex, pseudohermaphroditism, 
hermaphroditism, sex reversal, and gender-based diagnostic labels”, which had been 
criticized as imprecise and stigmatizing (Dreger, Chase, Sousa, Gruppuso, & Frader, 2006; 
Dreger, Chase, Sousa, Gruppuso, & Frader, 2005; Houk, Lee, & Rapaport, 2005). A more 
appropriate terminology, the Chicago consensus argued, should be:  
(1) Precise when applying definitions and diagnostic labels,  
(2) Flexible to incorporate new information, yet robust enough to maintain a consistent 
framework,  
(3) Descriptive and reflecting genetic aetiology when available and accommodate the 
spectrum of phenotypic variation,  
(4) Valued by clinicians and scientists,  
(5) Understandable to individuals and their families,  
(6) Sensitive to the concerns of individuals with these conditions (Lee et al., 2006). 
According to the Chicago consensus, conditions can be classified into three groups depending 
on karyotype and pathogenesis: sex chromosome DSD, XY DSD and XX DSD. Sex 
chromosome DSD includes mixed gonadal dysgenesis (46,XY/45,XO), 46,XY/46,XX 
conditions as well as Turner syndrome and Klinefelter syndrome. XY DSD incorporates XY 
gonadal dysgenesis, androgen insensitivity syndrome (AIS), disorders of androgen synthesis, 
disorders of AMH synthesis and action, and severe hypospadias. The XX DSD category 
includes congenital adrenal hyperplasia (CAH), XX gonadal dysgenesis, and uterine and 
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vaginal anomalies. Thus, the umbrella term Disorders of Sex Development includes conditions 
with diverse genetic aetiology, varying levels of prenatal androgen effects, and varying 
phenotypes of genitalia (Jürgensen et al., 2010). It is recognized that this is not an ideal 
classification as, for example, ovotesticular DSD karyotypes vary to a large degree and may 
be listed within any of the three categories. 
Today, the new nomenclature is widely accepted, although not by all clinicians and 
researchers (Pasterski et al., 2010a). Some authors argue that the diagnosis CAH should not 
be included in Disorders of Sex Development, since in most cases gender identity and gender 
assignment is not problematic. Also, males with CAH do not present with developmental 
problems of the reproductive system (Gonzalez & Ludwikowski, 2016). The ESPE Diagnosis 
Classification published in 2007 stated that “disorders of gonadal differentiation, that do not 
result in sex reversal/virilised female infant/under virilised male such as: Klinefelter 
syndrome and Turner syndrome” should be excluded from the section sex chromosome DSD 
(Wit et al., 2007), contrary to the inclusive approach of the Chicago consensus (Pasterski et 
al., 2010b). A search in PubMed over the last decade shows that in publications on “Turner 
syndrome” only 2.6%, and on “Klinefelter syndrome” only 4.4%, mention the term Disorders 
of Sex Development. Rather than using Disorders of Sex Development, some authors prefer 
umbrella terms like ambiguous genitalia (Michala et al., 2014), intersex (Kraus, 2015; 
Lathrop et al., 2014) or intersex/DSD (Roen & Pasterski, 2013) for conditions which could 
be labelled as Disorders of Sex Development. 
Although the Chicago consensus aimed at replacing potentially stigmatizing vocabulary by 
less controversial terms, the new terminology nevertheless resulted in criticism (Clune-
Taylor, 2010; Diamond & Beh, 2006; Feder, 2009; Feder & Karkazis, 2008; Guntram, 2013; 
Hughes, 2015; Hughes et al., 2007; Liao & Roen, 2013; Lin-Su et al., 2015; Simmonds, 
2007). Some critics complained that international peer support groups had not sufficiently 
been consulted when creating the new term. The term disorder was seen as unnecessarily 
pathologizing, falsely implying that all persons with Disorders of Sex Development are in need 
of surgical or hormonal intervention, whereas that some or all conditions labelled as 
Disorders of Sex Development could be considered variants of the normal (Diamond & Beh, 
2006; Reis, 2007). Consequently, alternative terms like Variations of Reproductive 
Development or Variations of Sex Development have been proposed (Diamond & Beh, 2006; 
Simmonds, 2007). Some authors avoid the term disorder by using DSD as an acronym for 
Differences of Sex Development, Divergences of Sex Development or Diverse Sex Development 
(Brunner et al., 2016; D'Alberton et al., 2015; Liao & Simmonds, 2013; Reis, 2007; Roen, 
2019; Schweizer et al., 2013; Streuli et al., 2012; Streuli et al., 2013; Tamar-Mattis et al., 
2013; Wiesemann et al., 2010). There is an ongoing controversy between some health 
professionals and some support groups over the use and understanding of the term Disorders 
of Sex Development. This may also explain why some clinicians apparently do not value its 
use.  
Yet, in spite of the ongoing controversy among experts, there is insufficient empirical 
evidence on how individuals having conditions that might be classified as Disorders of Sex 
Development think about the terminology themselves. In a UK study with a rather small 
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sample of parents of children having Disorders of Sex Development, 18 out of 19 preferred 
the term Disorders of Sex Development over the term intersex, yet, only 7 agreed that Disorders 
of Sex Development was an acceptable term to describe an individual’s overall condition when 
it has not been possible to assign them male or female at birth (Davies et al., 2011). In-depth 
interviews with 37 participants from the USA who were all familiar with the term Disorders 
of Sex Development also indicated that the term was not uniformly accepted by those it 
purports to describe (Davis, 2013). Interviews with individuals with Turner syndrome and 
Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome from Sweden showed that none of the 
interviewed persons (N = 23) used the term Disorders of Sex Development (Guntram, 2013). 
Another study in the US examining via e-mail survey the views of 128 women with CAH and 
408 parents or other family members showed that only 1.0% of the total cohort had a 
favourable opinion of the term Disorders of Sex Development, whereas over 71.0% disliked or 
strongly disliked it (19.1% neutral, 8.9% don’t mind it) (Lin-Su et al., 2015). In a study 
evaluating the opinions of 202 members of an AIS support-group, only 17% liked the term. 
The majority preferred intersex, Variation in Sex Development, and Difference of Sex 
Development over Disorders of Sex Development (Johnson et al., 2017). A qualitative interview 
study with 33 parents and 22 young people with personal experience of intersex/DSD showed 
that the vast majority of participants across samples agreed that DSD understood as Disorders 
of Sex Development was a negative term, even though some thought it was accurate 
(Lundberg, Hegarty, & Roen, 2018).  
These studies show that there are equivocal opinions on the term Disorders of Sex 
Development, although many participants seem to dislike the term. However, the empirical 
evidence, so far, does not justify generalized conclusions. Most studies include only small 
samples sizes (Davies et al., 2011; Davis, 2013; Guntram, 2013; Lundberg et al., 2018), two 
studies only recruited parents (Davies et al., 2011; Tiryaki et al., 2018), and in one study the 
majority of participants were parents or other family members (Lin-Su et al., 2015). In one 
study, the medical condition of the participants was unclear (Guntram, 2013). In one study 
individuals with CAH and XY karyotype were included, although this condition is not covered 
by the DSD classification (Lin-Su et al., 2015). Finally, in many studies participants were 
recruited through support groups and therefore samples might not represent the views of 
individuals who are not organized in such groups.  
To date, the views of individuals representing the full range of conditions that could be 
classified as Disorders of Sex Development (DSD) have not been systematically evaluated. 
There is no conclusive evidence whether these individuals feel that the term Disorders of Sex 
Development applies to their condition, whether they prefer other terms and whether their 
views are related to their respective medical condition. Moreover, the reluctance of some 
clinicians to adopt the DSD classification scheme may be because of uncertainty regarding 
their patients’ concerns and objections. Thus, it is unclear whether the use of this terminology 
in clinical contacts should be recommended or not.  
The current study addressed these questions using a large dataset from a quantitative cross-





In total, 1,040 individuals with congenital atypical development of chromosomal, gonadal 
or anatomical sex were recruited. Recruitment took place in Poland (Pl), Sweden (S), 
Germany (D), France (F), United Kingdom (UK) and the Netherlands (NL) between 2014 
and 2015. Inclusion criteria of the study followed a generic definition of DSD as 
incongruence of the chromosomal, gonadal, and phenotypic sex with a laboratory-confirmed 
diagnosis or clinical diagnosis by a physician. Participants were classified into five diagnosis 
groups: CAH, Turner syndrome, Klinefelter syndrome, conditions with XY karyotype, and 
participants with conditions that do not fit into the other groups (“other conditions”) (Table 
I.1). This was deemed necessary to clarify if the medical condition and related experiences 
were associated with participants’ view on the terminology. The most frequent conditions 
were CAH, Turner syndrome, and Klinefelter syndrome. Given the varying incidences of 
conditions labelled as Disorders of Sex Development, and in order to build comparable group 
sizes, different rare conditions with XY karyotype were summarized in one separate group, 
in accordance with the proposed DSD classification “XY DSD”. Participants with some 
extremely rare conditions were grouped separately. If sample sizes of subgroups with 
different rare conditions in the heterogeneous groups XY karyotype and other conditions 
were large enough, data were analysed quantitatively. This was possible for complete AIS, 
partial AIS, complete and partial gonadal dysgenesis, XX gonadal dysgenesis, hypospadias, 
17-beta HSD, 45,X/46,XY and others with Y material. Overall, 173 (17.8 %) participants had 
contact with a support group within the last 12 months (by country: Pl 6.7%, S 15.4%, D 
19.2%, F 4.4%, UK 28.6%, NL 35.3%). Other sample characteristics were described in detail 









Table I.1. Description of the cohort and group classification 
Group CAH Turner Klinefelter conditions with XY Karyotype  Other conditions 
 n = 226 n = 301 n = 218 n = 222 n = 73 
Medical condition Salt-wasting (n=111), 





deficiency (n=6), POR 






Polyploidy (n=16), Ring 
material [45,X/46,X,r(X)] 
(n=12), Not to classify and 
unknown (Turner) (n=14) 
47,XXY (n=204), 
47,XXY/46,XY (n=6), 
47,XXY/46,XX (n=3),  
Not to classify and 
unknown (Klinefelter) 
(n=5) 
Complete gonadal dysgenesis 
(n=21), Partial gonadal 
dysgenesis (n=37), XY ovotestis 
(n=5), cAIS (n=71), pAIS 
(n=35), 3b-hydroxylase 
deficiency (n=2), 17-beta HSD 
(n=11), 5-alpha RD (n=4), 17-
Hydroxylase/ 17,20 lyase defect 
(n=1), Hypospadias (n=25), 
Not to classify and unknown 
(with XY Karyotype) (n=10) 
45,X/46,XY and others with 
Y material (n=45),  
47,XYY (n=1),  
XX gonadal dysgenesis 
(n=20),  
XX ovotestis (n=1),  
46,XX testicular males (n=6) 
 n % n % n % n % n % 
Germany 91 40.3 43 14.3 38 17.4 57 25.7 15 20.5 
France 62 27.4 116 38.5 26 11.9 42 18.9 28 38.4 
The Netherlands 27 11.9 82 27.2 88 40.4 46 20.7 7 9.6 
Poland 15 6.6 3 1 23 10.6 54 24.3 12 16.4 
Sweden 12 5.3 46 15.3 35 16.1 18 8.1 11 15.1 
United Kingdom 19 8.4 11 3.7 8 3.7 5 2.3 0 0 
Age            
mean (sd) 30.44 (11.38) 32.23 (13.28) 39.56 (15.25) 28.79 (12.24) 28.19 (11.5) 
<19 years 40 17.7 54 17.9 28 12.8 51 23.0 20 27.4 
20-24 46 20.4 59 19.6 17 7.8 51 23.0 12 16.4 
25 - 44 112 49.6 130 43.2 89 40.8 93 41.9 34 46.6 
≥45 28 12.4 58 19.3 84 38.6 27 12.2 7 9.6 
Contacted support group in the past 12 month  
No 189 87.5 217 77.2 163 81.1 172 82.3 60 89.6 
Yes 27 12.5 64 22.8 38 18.9 37 17.7 7 10.4 
CAH= congenital adrenal hyperplasia, AIS= androgen insensitivity syndrome: cAIS= complete androgen insensitivity syndrome, pAIS= partial androgen insensitivity  







A multicentre clinical evaluation study was initiated as part of the European research group 
dsd-LIFE, funded by the European Union Seventh Framework Programme (FP7/ 2007-
2013). Details of the study design were described previously (Rohle et al., 2017). All 
participants gave written informed consent for the study. 
Measures 
All participants were asked whether the term Disorders of Sex Development applied to their 
medical condition: “The term Disorders of Sex Development applies to my medical condition”. 
Response options were: strongly agree, partly agree, neither agree nor disagree, partly 
disagree, strongly disagree.9  
Additionally, participants were asked to rate a number of alternative terms. They were 
derived from a literature survey and feedback from advocacy and support groups. Since the 
study was performed in six European countries, terms were translated in compliance with 
the linguistic validation process of the international translation guidelines	 (Rohle et al., 
2017). Participants answered the questions (a) “Which of the following terms should be used 
by doctors to describe your condition in medical terms?”, (b) “Which term do you prefer to 
use for your condition in everyday life e.g. with friends, family, colleagues?”. They could 
choose up to ten term from various terms from a list (Table I.3) and, if deemed necessary, 
also insert new ones. Rating was on a Likert scale from 10 = very good to 0 = very bad. 
Alternative terms were later classified into four groups: (i) potential umbrella terms for all 
conditions, (ii) umbrella terms including a potentially pathologizing messages such as 
disorder, dysgenesis or defect, (iii) umbrella terms without pathologizing messages, and (iv) 
terms applying only to specific conditions (see Table I.3). Because of its prominence in the 
literature, the term intersex was analysed separately. Rating of alternative terms was 
optional, in order not to burden participants with too many obligatory questions.  
Statistical analysis 
In order to analyse the influence of (1) age, an ordered logistic regression model with age 
as the only parameter was applied. Moreover, we analysed the association between the views 
on Disorders of Sex Development and 2) being a member of a support group, (3) recruitment 
country, and (4) diagnosis group using χ2 tests and (5) small diagnosis subgroups using 
Fisher’s exact test. Post-hoc comparisons were done with the χ2 test (diagnosis group) and 
Fisher’s exact test (country). 
Regarding alternative terms that could be used by (a) doctors and (b) in everyday life, no 
detailed statistical analysis was possible, since rating was optional and not all individuals 
rated all terms. The groups rating specific terms cannot be regarded as independent from 
each other and, therefore, no inter-individual and no intra-individual testing was done. 
Terms are presented using the mean values of their ratings (integers from 0 – very bad to 10 
 
9 Since we wanted to assess the participants’ understanding of the term, we did not provide an explanation of 
the DSD terminology. 
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– very good; regarded as continuous) and standard deviations. In order to compare ratings 
of two terms or two groups of terms, differences in ratings were calculated and expressed in 
relation to their pooled standard deviation. If terms were to be grouped (i-iv), their weighted 
mean values and pooled standard deviations were used.  
The term “intersex” was assessed separately using simple, linear regression to identify 
associations of ratings to (1) age, (2) being a member of a support group, (3) country, and 
(4) diagnosis group.  
Due to the exploratory nature of the analysis, p values were considered non-confirmatory 
and no adjustment for multiple testing was done. R (version 3.2.2) was used for all analyses 
(R_Core_Team, 2016). 
Results 
Disorders of Sex Development 
Results for the question “The term Disorders of Sex Development applies to my medical 
condition” are presented in Table I.2 and Figure I.1. No association with (1) age and (2) 
being a member of a support group could be identified (data not shown). There was an 
association between ratings of the term Disorders of Sex Development (3) and recruitment 
country (p < 0.001) (Figure I.2). The post hoc tests showed that participants from Poland 
and Sweden rated the terminology more positive than participants from the other countries 
(post hoc test with p<0.05: Pl vs. D, F, NL, S; S vs. F, NL; D vs. NL). An association between 
ratings of the term Disorders of Sex Development and (4) diagnostic group was identified (p 
< 0.001) (Figure I.2). Post hoc tests showed that participants with XY karyotype in particular 
rated the terminology more positive than the Turner, Klinefelter, and CAH groups (post hoc 
with p < 0.01: XY karyotype vs. Turner, Klinefelter and CAH). There was an association 
between the ratings of Disorders of Sex Development and (5) small diagnosis subgroups (p < 
0.001). Participants with conditions with no androgen effect on phenotype (complete AIS, 
complete gonadal dysgenesis, XX gonadal dysgenesis), and participants with hypospadias 
rated Disorders of Sex Development less positively than participants having conditions with 
androgen effect (partial AIS, partial gonadal dysgenesis, 45,X/46,XY and others with Y 




Figure I.1. Participants’ responses to the statement “The term 












Figure I.2. Participants’ responses to the statement “The term Disorders of Sex Development applies to 





















































































Table I.2. Participants’ responses to the statement “The term Disorders of Sex Development applies to 
my medical condition” 
  Strongly 
agree Agree Neutral Disagree 
Strongly 
disagree Total 
















































































































































































































45,X/46,XY and others  








































A minority of the cohort chose to rate alternative terms (Table I.3). Participants who rated 
Differences of Sex Development had a slightly better opinion about this term than participants 
who rated Disorder of Sex Development (see Table I.3). On average, (i) potential umbrella 
terms were rated positively (m = 5.49, pooled sd = 3.37). The weighted mean of (ii) 
potentially pathologizing and of (iii) non-pathologizing terms differed in 0.01 pooled 
standard deviations only (m = 6.24, pooled sd = 3.13 to m = 6.26, pooled sd = 3.05). (iv) 
Specific terms (m = 7.86, pooled sd = 2.98) were rated 0.75 pooled standard deviations 
better than umbrella terms.  
Participants were asked to rate terms with regard to usage in (a) medical context as 
compared to (b) everyday life. In most cases ratings of the terms in (a) medical context and 
(b) everyday life differed less than 0.25 pooled standard deviations (data are not presented). 
With respect to five terms the ratings of (a) and (b) differed more than 0.25 (but less than 
0.5) pooled standard deviations. Participants rated four specific terms (hormonal disorder of 
the gonads, XXY, complete AIS and 21-hydroxylase deficiency) slightly better, if used by (a) 
doctors (m = 6.25, sd = 3.1/ m = 7.55, sd = 3.07/ m = 8.14, sd = 2.88/ m = 7.54, sd = 
2.78) as compared to in (b) everyday life (m = 5.27, sd = 3.17/ m = 6.62, sd = 3.56/ m = 
7.29, sd = 3.25/ m = 6.16, sd = 3.2). In contrast, the term intersex was rated slightly more 
positively if used in (b) everyday life (m = 5.75, sd = 3.72) as compared to by (a) doctors 
(m = 4.6, sd = 3.6).  
Figure I.3 shows the distribution of the ratings of the terms intersex, Disorders of sex 
Development and Differences of Sex Development. There was no association between 
participants’ views of the term intersex and (1) age, (3) country, or (4) diagnosis group (data 
are not presented). Participants who had engaged in (2) support groups in the last 12 months 
rated intersex better than other participants (no support group membership: m = 3.94; 




Table I.3. Participants’ responses to the question “Which of the following terms 
should be used by doctors to describe your condition in medical terms?”  
 n mean sd 
(i) Potential umbrella terms:     
DSD as 'Disorder of Sex Development' 282 5.23 3.5 
DSD as 'Difference of Sex Development' 159 5.93 3.18 
DSD as 'Diverse Sex Development' 98 5.05 3.32 
VSD as 'Variation of Sex Development' 139 5.82 3.38 
(ii) Umbrella terms with a potential pathological message:  
Hormonal disorder of the gonads 81 6.25 3.1 
Hormonal disorder of the adrenals 79 6.96 2.89 
Hormonal disorder 248 6.05 3.1 
Metabolic disorder 127 6.5 3.31 
Genetic condition 260 6.68 2.86 
Genetic mutation 148 5.27 3.46 
Gonadal dysgenesis 79 5.92 3.53 
Adrenal enzyme defect 57 6.35 2.98 
(iii) Umbrella terms without a potential a pathological message: 
Hormonal imbalance of the gonads 73 5.71 3.12 
Hormonal imbalance of the adrenals 59 7.14 2.85 
Hormonal variation of the gonads 46 5.85 3.1 
Hormonal variation of the adrenals 42 6.36 2.99 
Hormonal variation 139 6.07 3.17 
Genetic variation 157 6.09 3.07 
Differences of sex chromosomes 220 6.36 2.99 
(iv) Specific terms:    
Turner syndrome 290 8.21 2.97 
Klinefelter syndrome 160 7.93 3.07 
XXY 120 7.55 2.92 
Congenital adrenal hyperplasia (CAH) 170 7.49 3.12 
Complete Androgen Insensitivity Syndrome (cAIS) 56 8.14 2.88 
Partial Androgen Insensitivity Syndrome (pAIS) 17 7.82 2.38 
21-hydroxylase deficiency 85 7,54 2,78 
Scale: 10=very good to 0= very bad; 5 = neutral; Answers to specific terms were only evaluated if 







Figure I.3. Participants’ responses to the question “Which of the following terms should be usedby doctors to describe your condition in medical terms?”; Distribution of 






Disorders of Sex Development 
Overall, a minority of 296 out of 941 participants (31%) reported that the term Disorder of 
Sex Development did not apply to their condition. This result is surprising given the rather 
critical appraisal of the term in other patient surveys (Clune-Taylor, 2010; Davis, 2013; 
Diamond & Beh, 2006; Feder, 2009; Feder & Karkazis, 2008; Guntram, 2013; Hughes, 2015; 
Hughes et al., 2007; Johnson et al., 2017; Liao & Roen, 2013; Lin-Su et al., 2015; Simmonds, 
2007). Rates varied according to country of origin and diagnosis group.  
Within the XY karyotype and “other conditions” groups, only 61 out of 271 (23%) objected 
to the use of Disorder of Sex Development. A detailed analysis showed that participants with 
partial prenatal androgen effect had the least negative view of the term Disorders of Sex 
Development.  
Thirty-eight percent of participants with CAH, 35% of those with Turner syndrome, and 32% 
of those with Klinefelter syndrome stated that the term Disorders of Sex Development does 
not apply to their condition. Hence, these responses differ from those of persons with CAH 
reported by Lin-Su et al. (2015).  
Overall, only a minority objected to the term Disorders of Sex Development. It may be 
advantageous for individuals with these rare conditions if their condition is classified as 
Disorders of Sex Development. Umbrella terms and classifications facilitate communication 
about different conditions; a consistent use, for example, between researchers and clinicians 
can render communication more precise and therefore improve clinical care and research. It 
can increase visibility and, thus, help to provide support for persons concerned. This might 
explain our observation that persons with rarer conditions tend to evaluate Disorders of Sex 
Development more positively. For individuals, there may also be a positive sense of belonging 
to a larger group with similar concerns. Disorders of Sex Development as an umbrella term 
may come as a relief because it implies that individuals have a condition “like many others” 
have - not a condition like “no one else” has (Feder, 2009). Also, participants with conditions 
with partial prenatal androgen effects might favour the term Disorders of Sex Development 
since it replaced even more controversial terms such as pseudohermaphroditism or 
hermaphroditism.  
Alternative terms 
When asked about other umbrella terms, no clear alternative preferences could be identified. 
Participants had the opportunity to rate an individual choice of terms. A total of 179 
participants chose to rate the term intersex, and 50 (28%) of these strongly disapproved of 
doctors using this term to describe their condition. In contrast, only 18% (50 out of 282) 
strongly disapproved of Disorders of Sex Development and only 13% (20 out of 159) of 
Differences of Sex Development. Persons disapproving of the term intersex were more likely 
not to be in contact with a support group. Support groups, thus, seem to promote a more 
positive view of intersex. Another explanation might be that individuals with a negative 
perception of the term intersex tend to avoid participating in support groups, especially since 
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some of them have the term intersex in their name. Since a number of previous studies 
recruited their samples from support groups (Davis, 2013; Johnson et al., 2017; Lundberg 
et al., 2018), this might explain why in our study the term intersex was rated less positively. 
In a medical as well as in a social sense, intersex can be interpreted in many different ways 
and there is no agreement on what intersex means or on what kind of conditions it comprises 
(Reis, 2007). This ambivalence is reflected in our study results. 
Other umbrella terms proposed in the literature like Variation of Sex Development, Differences 
of Sex Development, and Diverse Sex Development (D'Alberton et al., 2015; Diamond & Beh, 
2006; Liao & Simmonds, 2013; Streuli et al., 2012; Streuli et al., 2013; Tamar-Mattis et al., 
2013; Wiesemann et al., 2010) were rated more positively than intersex, despite the semantic 
issues sometimes associated with this terms. Moreover, we found no major differences 
regarding pathologizing and non-pathologizing terms. Ratings of Disorders of Sex 
Development were similar to those of Difference of Sex Development, Diverse Sex Development 
and Variations of Sex Development. Considering the intense debates about the potentially 
pathologizing message of the term disorder, this is a surprising result. Some persons may 
actually consider the term helpful because it helps them to understand their condition and 
opens up opportunities for medical care. Another explanation is that the majority of 
participants in our study were recruited at medical centres and therefore were used to 
medical terms such as disorder, mutation or defect.  
On average, terms were rated slightly better if they did not include the term Sex Development. 
This was true for both potentially pathologizing and non-pathologizing terminology. 
Moreover, participants favoured a nomenclature that described their somatic condition more 
precisely in terms such as gonads, adrenals, genetic or chromosomal as compared to a 
nomenclature which included the term sex, which may be interpreted as relating to sexuality, 
rather than anatomy (Lin-Su et al., 2015). They rated their respective individual diagnostic 
terms the highest. Thus, they favoured specific names over general ones, confirming results 
of previous studies (Lundberg et al., 2018; Tiryaki et al., 2018).  
Strengths and Limitations  
This study was part of a large European quantitative cross-sectional outcome study. Nine 
hundred forty-one individuals with conditions which are medically labelled as Disorders of 
Sex Development were included, so far, the largest cohort ever consulted regarding 
terminology. All somatic conditions were medically confirmed, thus securing that only 
participants affected by the DSD classification participated. We could therefore evaluate the 
views of individuals by diagnostic group and add more differentiated empirical data to the 
ongoing ethical debate. Nevertheless, quantitative data have limitations in explaining why 
individuals prefer specific terminology. Furthermore, a selection bias cannot be ruled out, as 
the study carried DSD in its acronym. Individuals who dislike the term Disorders of Sex 
Development might not have accepted the invitation to participate in this study. Though 
generalization is limited, it can be assumed that our results are applicable to individuals 
treated at clinical centres similar to the ones in this study. We did not ask whether 
participants were acquainted with the term Disorders of Sex Development and classification. 
Furthermore, one must be particularly careful with interpretations of the results regarding 
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alternative terms. Because of the option of multiple responses to each question, results may 
be biased by those agreeing to more than one response. Moreover, many participants chose 
not to rate all terms, this might be because they were indifferent regarding the terminology 
concerning their condition. Because participants with a distinctive opinion were more likely 
to rate the terms there was a bimodal distribution therefore, interpretability of the mean 
values is limited.  
General Discussion 
When in 2006 the Chicago consensus introduced the term Disorders of Sex Development 
(DSD), one goal was to render the new terminology more understandable to patients and 
their families and be sensitive to their concerns. Four years after the initial publication, 100% 
of the paediatric endocrinologists in Europe reported using the new terminology (Pasterski 
et al., 2010a) and between 2010 and 2014 there was an exponential increase in the use of 
the term Disorders of Sex Development across a range of journals (Hughes, 2015). Such a 
profound and rapid change in terminology is without parallel in recent medical practice 
(Pasterski et al., 2010a). Disorders of Sex Development can be considered as being a paradigm 
shift, not only in the use of a new nomenclature but also in the underlying classification 
(Khadilkar & Phanse-Gupte, 2014). However, since its introduction, the new term has 
attracted criticism by members of support groups, as well as ethicists, sociologists, clinicians, 
and researchers. The term disorder is said to pathologize atypical sex development and, thus, 
nurture the widespread, yet false, attitude that a medical, instead of a social or political, 
approach is appropriate. Empirical studies – quantitative as well as qualitative – conducted 
since 2006 appear to support the view that the term Disorders of Sex Development is not 
sensitive to patient concerns, but the evidence is still inconclusive. Some authors underline 
that the change of the nomenclature can also be understood as normalizing conditions 
labelled as Disorders of Sex Development in a positive sense (Feder, 2009).  
The purpose of this study was to ascertain the views of affected individuals on the term 
Disorders of Sex Development as a medical concept. From our results, it appears that the 
majority of participants in the dsd-LIFE cohort had a neutral or positive opinion about the 
term Disorders of Sex Development. The high acceptance rate applied to participants from all 
diagnosis groups, although participants with CAH, Turner, and Klinefelter syndrome were 
slightly less accepting. Participants did not show a tendency to prefer alternative terms with 
no pathologizing potential, and, in general, they appeared to prefer terms that were specific 
to their somatic condition over the general Disorders of Sex Development designation. Most 
interestingly, the term intersex which is often used by support groups was rated the lowest. 
Our data suggest that the aim of the Chicago consensus to eliminate stigmatizing 
terminology and to replace it by terms more sensitive to individuals with Disorders of Sex 
Development concerns was, at least partially, achieved, especially since acceptance rates were 
the highest in the group of participants with conditions that prior to 2006 had been labelled 
hermaphroditism and pseudohermaphroditism. However, objection rates of 32-38% in CAH, 
Turner, and Klinefelter syndromes and, particularly, of 37-40% in the Netherlands and 
France should caution clinicians and researchers against an uncritical use of the new 
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terminology. Depending on the condition, up to one out of four participants strongly objected 
to the term Disorders of Sex Development.  
In the clinical situation, we therefore recommend clinicians evaluate and be sensitive to their 
patients’ preferences. Specific terminology related to the individual’s somatic condition or 
diagnosis should be preferably used. In the context of healthcare research, a combination of 
the two most acceptable terms difference and disorder, as in Difference/Disorder of Sex 
Development, can be considered appropriate. However, since individuals in our cohort rated 
Differences the highest and given the fact that some critics strongly denounce the term 
disorder, Differences of Sex Development may be considered as the recommended alternative 
umbrella term. This would imply only a slight change in communicating with the patient 
about DSD: while one has a disease, one’s sex development is different, e.g. with regard to 
sex-typical characteristics. Overall, our data do not support the view that, in general, the 
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Objective: Rare congenital conditions with incongruence of chromosomal, gonadal, and 
phenotypic sex have been classified as Differences/ Disorders of Sex Development (DSD). 
Included in DSD are conditions with diverse genetic aetiology, varying levels of prenatal 
androgen effects, phenotypes, and subsequently, different medical treatments. Quality of life 
(QoL) and psychological wellbeing are indicators of successful psychosocial adaptation to 
the conditions. We sought to investigate the HRQOL and psychological wellbeing in this 
population.  
Design: This multicentre clinical evaluation study was part of a German network related to 
DSD funded by the German Ministry of Science and Education (BMBF 2003 to 2007).  
Methods: To assess health-related quality of life (HRQoL), we used the Short Form Health 
Survey (SF-36) and for psychological wellbeing, the Brief Symptom Inventory (BSI). 
Participants were classified into five groups: females with CAH, females with XY DSD 
conditions where there is a partial androgen effect (partial androgen insensitivity, mixed/ 
partial gonadal dysgenesis, disorders of androgen biosynthesis), females with XY DSD 
without androgen effect (complete androgen insensitivity, complete gonadal dysgenesis), 
males with XY DSD, and individuals with DSD conditions and a other gender. 
Results: Participants included 110 adults with DSD (age range 17-62). We found a trend of 
lowered mental HRQoL and significant higher physical HRQoL for participants as compared 
to a norm. The high physical HRQoL especially applied to females with androgen effect and 
XY karyotype. Participants reported significant higher psychological distress compared to the 
norm. Forty-seven participants (42.7%) reported distress in a clinically relevant range on the 
BSI.  
Conclusions: Although we did not find significant impairments in overall HRQoL, participants 
reported significant impaired psychological wellbeing. Specialized interdisciplinary care 
should focus in particular on psychological issues to ensure overall good health and 
wellbeing. 
Introduction 
Rare congenital conditions with incongruence of chromosomal, gonadal, and phenotypic sex 
characteristics are medically classified as Differences/ Disorders of Sex Development (DSD) 
(Lee et al., 2006). DSD include conditions with diverse genetic aetiology, varying levels of 
prenatal androgen effects, as well as varying phenotypes of genitalia. Subsequently, medical 
treatments differ for the conditions (Jürgensen et al., 2010). In 2005, the Chicago DSD 
Consensus Group on Management of Intersex Conditions introduced the umbrella term 
Disorders of Sex Development (DSD). The term was chosen to replace nomenclature such as 
intersexuality, hermaphroditism, or testicular feminization (Lee et al., 2006). According to 
the Chicago DSD Consensus Group, conditions included in DSD are classified into three 
groups according to the karyotype and pathogenesis: 1. Sex chromosome DSD that includes 
46,XY/45,XO and 46,XY/46,XX conditions, as well as Turner syndrome and Klinefelter 
syndrome.; 2. XY DSD that encompasses XY gonadal dysgenesis, androgen insensitivity 
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syndrome (AIS), impaired androgen or anti-Müllerian hormone synthesis or action, and 
unclassified severe hypospadias; and 3. XX DSD which comprises congenital adrenal 
hyperplasia (CAH), XX gonadal dysgenesis and uterine and vaginal anomalies (Lee et al., 
2006). 
The term “Disorders of Sex Development” is controversial within interdisciplinary teams and 
affected individuals as it is perceived as pathologizing and might be confused with aberrant 
sexuality or gender identity (Lin-Su et al., 2015). The authors therefore prefer “Differences 
in Sex Development”, which was introduced by other researchers (Brunner et al., 2016; 
D'Alberton et al., 2015; Roen & Pasterski, 2013). Depending on the impact of androgens, the 
functional impairment of the gonads and the reproductive system DSD can have different 
effects on the individuals’ body and health. Medical treatments, such as hormonal therapy 
or surgical interventions, are often necessary. Two indicators of successful adaptation to the 
condition are quality of life (QoL) and psychological wellbeing. The World Health 
Organization (WHO) defines QoL as, “the individual’s perception of their position in life in 
the context of the culture and value system in which they live, and in relation to their goals, 
expectations, standards, and concerns”. Although there is overlap in the two concepts, 
psychological wellbeing refers to distress and symptoms of psychiatric disorders.  
Until 1999, no studies adequately addressed QoL for individuals with DSD (Meyer-Bahlburg, 
1999; Schober, 1999b). Recently, an increasing number of psychologically oriented outcome 
studies assessing a wider range of psychosocial and psychosexual outcomes have been 
performed (Roen & Pasterski, 2013). Reviews on QoL and psychological outcomes for adults 
with DSD cited nine original articles from 1995 to 2004 and fifteen from 2005 to 2014 
(Nordenstrom, 2015; Schützmann et al., 2009; Wisniewski & Mazur, 2009; Zainuddin et al., 
2013). In 2015, five novel studies were published (D'Alberton et al., 2015; Ediati et al., 2015; 
Ediati et al., 2015; Engberg et al., 2015; Wang & Tian, 2015). Although these studies address 
QoL and/or psychological wellbeing of individuals with DSD, the results varied greatly. 
Reviews highlighted the poor research status and concluded that all conditions are 
understudied (Wisniewski & Mazur, 2009). In addition, the studies are hardly comparable 
due to different diagnostic groups, heterogeneous samples, marked variations in overall 
quality, age groups, small sample sizes, and recruitment strategies. Consequently, the results 
are inconsistent and many findings cannot be generalized as almost all studies were limited 
by a selection bias (Schützmann et al., 2009). Additionally, it is difficult to compare the 
results directly due to many differences in the methodologies (Zainuddin et al., 2013). A 
wide spectrum in QoL is expressed by individuals with DSD ranging from very poor to similar 
to better than the norm population (Amaral, Inacio, Brito, Bachega, Domenice, et al., 2015; 
D'Alberton et al., 2015). Better QoL ratings were found for individuals with DSD from 
tertiary care centres (Amaral, Inacio, Brito, Bachega, Oliveira, et al., 2015; Wang & Tian, 
2015). Even in studies using the same method the findings varied (Zainuddin et al., 2013). 
It can be concluded that the results concerning QoL and psychosocial outcomes in individuals 
with DSD are both scarce and inconsistent (Nordenstrom, 2015). 
This study is a part of the clinical evaluation study of the German DSD network investigating 
the clinical outcomes and health care situation of children, adolescents, and adults with DSD 
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from 2005 to 2007 (Lux et al., 2009). It was the first multicentre outcome study in this field 
including individuals with DSD conditions following the generic definition of a discrepancy 
of chromosomal, gonadal and phenotypical sex (excluding Klinefelter and Turner 
Syndromes) in German speaking countries. In this sub-study, we analysed the HRQoL and 
psychological wellbeing in a sample of 110 adults with rare DSD conditions using 
standardized instruments with normative data for the general population available.  
Methods 
Study design  
This multicentre clinical evaluation study was part of the larger German network of 
individuals with DSD, funded by the German Federal Ministry of Education and Research 
(BMBF). The details of the study design were described previously (Lux et al., 2009). 
Recruitment took place at four study centres in Germany and at five sites in Austria and 
Switzerland between January 2005 and December 2007. Most adult participants were 
recruited via doctors from the study centres or cooperation partners, support groups 
recruited 16 participants. There were no differences between non-participants (23.6% of 
those approached) and participants regarding sociodemographic data or type of diagnosis 
(Lux et al., 2009). Inclusion criteria of the study followed a generic definition of DSD as 
incongruence of the chromosomal, gonadal, and phenotypic sex with a laboratory-confirmed 
diagnosis or clinical diagnosis by a physician. Individuals with Klinefelter and Ullrich-Turner 
syndrome were excluded10. None of the adult participants had to be excluded due to their 
inability to respond to the interview due to mental illness or intellectual disability. Trained 
psychologists conducted personal interviews and assessments of the participants at the study 
centres or at participant’s home, depending on preferences of the participants. The 
psychologists had been recruited by the study and were not involved in routine care and not 
been known to the participants prior to the study. All participants gave written informed 
consent for the study.  
This study aimed to describe	the	health related QoL (HRQoL) and psychological wellbeing 
of adults with DSD. In order to construct groups with similar conditions, participants were 
classified into five groups reflecting gender at the time of the interview, diagnosis and 
exposure to prenatal androgen effects affecting sex development: females with congenital 
adrenal hyperplasia (CAH), participants with female (f) or male (m) gender, XY DSD with 
partial (pa) or no (na) androgen effects, participants with various conditions and a different 
gender from male or female (f-CAH-pa, f-XY-pa, f-XY-na, m-XY-pa, other gender). The 
subgroups of this analysis differ slightly from previous subgroup analysis of the cohort using 
the classification: DSD-XX-P-F, DSD-XY-P-F, DSD-XY-C-F, and DSD-XY-P-M (Köhler et al., 
2012; Lux et al., 2009; Thyen, Lux, Jurgensen, Hiort, & Kohler, 2014). The group f-CAH-pa 
includes only females with CAH from the previous group DSD-XX-P-F. Participants with other 
gender were separated from the previous groups DSD-XY-P-F, DSD-XY-C-F, and DSD-XY-P-
M (Table II.1). The evaluation was performed on the total cohort and between groups. 
 
10 Nevertheless one individual with 47,XXY participated 
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Participants with gender changes and conditions not fitting the five groups are described 
within the total cohort but are excluded from group comparison. These single case 
descriptions are not shown, as they are anecdotic and there is risk to confidentiality due to 
ease of recognition of these individuals. 
Health-related quality of life 
To assess HRQoL, the German version of the Short Form Health Survey (SF-36) was used. 
The SF-36 is a well-evaluated standardized instrument including eight subscales and two 
summary measures: a physical component summary (PCS) and a mental component 
summary (MCS). The PCS includes physical function, physical role, bodily pain, and general 
health. The MCS includes vitality, social function, emotional role, and mental health with 
varying response categories (Cronbach’s alpha >.85). Higher scores indicated better HRQoL 
(Bullinger & Kirchberger, 1998). Our z-scores were calculated with reference data from the 
German norm population of the 1998 German National Health Survey (N = 6967), taking 
into consideration age and gender. For participants with other gender only age was 
considered.  
Psychological wellbeing 
Psychological wellbeing was assessed with the German version of the Brief Symptom 
Inventory (BSI), which is a short version of the Symptom-Checklist-90 (SCL-90) (Derogatis, 
Lipman, Rickels, Uhlenhuth, & Covi, 1974). This instrument includes 53 items on nine 
subscales (somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, 
hostility, phobic anxiety, paranoid ideation, and psychoticism) and three global 
characteristic values: global severity index (GSI), positive symptom total (PST), and positive 
symptom distress (PSD). Participants rated the extent to which they have been bothered 
(0=not at all to 4=extremely) in the past week by various symptoms. Higher scores indicated 
a higher level of psychological distress (Franke, 2000). The absolute BSI values were 
transformed into T-scores (considering gender) in respect to a German norm population 
(N=600)(Franke, 2000). Participants that had T-scores≥63 indicated significant distress on 
the BSI. Criteria for being classified as a clinical case were either a Global Severity Index of 
T≥63 or two single subscale scores of T≥63 (Schützmann et al., 2009). 
Statistical analysis  
SPSS Version 22 was used for all analyses. The nonparametric Wilcoxon test was used to 
evaluate group median differences from the norm population. The p values were calculated 
with the nonparametric Wilcoxon signed rank test against test value z=0.00 or T=50.00. 
The Kruskal-Wallis test followed by Dunn-Bonferroni test as pairwise post hoc test was used 




Table II.1: Definitions and conditions of the groups  
Group Definition Condition 
f-CAH-pa 
n=44 
Participants indicating having a 
female gender, 46,XX DSD due to 
CAH 




Participants indicating having a 
female gender, 46,XY DSD or sex 
chromosome mosaicism and partial 
androgen effects 
13 partial/ mixed gonadal dysgenesis  
6 pAIS  
3 17beta-hydroxysteroid- dehydrogenase III 
deficiency  
2 5alpha-reductase II deficiency  




Participants indicating having a 
female gender, 46,XY DSD and no 
androgen effects 
5 complete gonadal dysgeneses  
8 cAIS  
m-XY-pa 
n=10 
Participants with male gender, 46,XY 
DSD or sex chromosome mosaicism 
and partial androgen effects 
3 partial/mixed gonadal dysgenesis 
1 pAIS 
3 severe hypospadias 
1 ovotestis  
1 epispadias  




Participants indicating having a 
different gender from female or male 
with 46,XY DSD or mosaicism 
2 partial/mixed gonadal dysgenesis 
1 complete gonadal dysgenesis 
3 cAIS 
1 pAIS 
1 5alpha-reductase II deficiency 




Participants included in the total 
cohort but excluded from group 
comparison  
Females: 
1 pAIS with gender change at 30 years 
(46,XY) 
1 penile agenesis and gender change the age 
of 1month (46,XY) 
1 Klinefelter syndrome with gender change at 
the age of 20 years (46,XXY) 
1 aromatase deficiency (46,XX) 
1 ovarian insufficiency (46,XX) 
1 complete gonadal dysgenesis (46,XX) 
Males: 
2 CAH (46,XX); one had a gender change at 
the age of 20 years 







In total 110 adults with DSD participated (age range 17-62; Table II.2). 101 participants 
reported to have a female (n=89, 80.9%) or male (n=12, 10.9%) gender. Nine individuals 
(8.2%) reported a gender different from male or female (Table II.3). Participants, whose 
conditions did not fit into the classified groups were excluded from group comparison (n=8) 
but were included in the description of the total sample (Table II.1). 
Table II.2: Sociodemographic data 
 
total¹  f-CAH-pa  f-XY-pa  f-XY-na  m-XY-pa  other 
gender 
N 110¹  44  26  13  10  9 














Age range in years 17-62  17-48  17-62  17-40  17-50  22-49 
 n %  n %  n %  n %  n %  n % 
Migration background 12 10.9  3 6.8  6 23.1  -   2 20.0  -  
Education level²          
Low 22 21.6  10 23.8  3 12.5  1 8.3  1 14.3  1 11.1 
Medium 34 33.3  20 47.6  7 29.2  3 25.0  3 42.9  -  
High 29 28.4  8 19.1  7 29.2  5 41.7  3 42.9  5 55.6 
Very high 17 16.7  4 9.5  7 29.2  3 25.0  -   3 33.3 
Living in current 
partnership 44 43.6  14 31.8  13 50.0  9 69.2  1 10.0  6 66.7 
Member of a DSD 
association or support 
group 
21 19.1  1 2.3  6 23.1  5 38.5  -   8 88.9 
¹Including single case descriptions; ²missing data n=8 
 
Table II.3: Description of the group “other gender”  
Current gender¹ Grew up as condition  
third gender female complete gonadal dysgenesis 
„female hermaphrodite“ female cAIS 
third gender female cAIS 
“official as female, but I 
cannot identify with this” 
female cAIS 
“intersexual female” female 17beta-hydroxysteroid- 
dehydrogenase III deficiency 
Undecided female partial gonadal dysgenesis 
Undecided female 5alpha-reductase II 
deficiency 
third gender female mixed gonadal dysgenesis 
“in private human, work-related 
male” 
female (gender 
change from male to 
female as a toddler)² 
pAIS 
¹categories of answer: female, male, third gender, undecided, other: ___; ²second gender change at 
the age of 30 years from female to male. cAIS= complete androgen insensitivity syndrome. pAIS= 




Health-related quality of life  
The total sample reported higher physical HRQoL (PCS) as compared to the population 
reference data (Table II.4). In the total cohort, we found higher scores in the subscale bodily 
pain (indicating lower levels of pain) and lower scores in physical function and physical role. 
The effects were explained by significantly better HRQoL in the subscale bodily pain in f-
CAH-pa and better HRQoL in all subscales of the physical summary score (PCS) in f-XY-pa. 
Nevertheless, there was no significant group difference in overall physical HRQoL (PCS), but 
significant group differences in the subscales physical function (p=.025; post-hoc: m-XY-
pa<f-XY-pa; p=.044 & f-CAH-pa<f-XY-pa; p=.093), bodily pain (p=.009; post-hoc: m-XY-
pa<f-CAH-pa; p=.030), and general health (p=.023; post-hoc: m-XY-pa<f-XY-pa; p=.036). 
There were no significant differences between females with simple virilising or salt wasting 
CAH (data not shown). Regarding mental HRQoL, we found a trend of lower mental HRQoL 
(MCS) that failed to reach significance in comparison to norm data. In comparisons between 
groups we found significant group differences in the subscale emotional role (p=.006; post-
hoc: f-XY-pa>other gender; p=.069 & f-CAH-pa>other gender; p=.013).  
Psychological wellbeing  
Participants reported significantly higher distress compared to the norm on most subscales 
of the BSI such as obsessive-compulsive, interpersonal sensitivity, depression, anxiety, 
hostility, paranoid ideation, psychoticism (Table II.4). Only the subscales somatization and 
phobic anxiety participants reported distress similar to the norm. Within the subgroups, most 
of this difference failed to be significant. There were significant group differences on the 
subscales phobic anxiety (p=.006; post-hoc: f-CAH-pa<other gender; p=.021 & f-CAH-
pa<m-XY-pa; p=.055) and psychoticism (p=.005; post-hoc: f-CAH-pa<other gender; 
p=.0391 & f-CAH-pa<m-XY-pa; p=.069). No significant differences were found between 
females with simple virilising or salt wasting CAH (data not shown). Forty-seven participants 
(42.7%) reported in a clinically relevant range on the BSI (clinical case). There was a 
significant correlation between mental HRQoL (MCS) and psychological wellbeing (GSI) 






Table II.4: Comparison of the total sample and the subgroups to population based reference data.  
 total¹  f-CAH-pa  f-XY-pa  f-XY-na  m-XY-pa  other gender  
group 
differences 
N 110¹  44  26  13  10  9  
SF-36 z sd      z sd  z sd  z sd  z sd  z sd  
physical function -.04 1.04 * -.23 1.23 .35 0.41 ** -.04 1.27 -.02 0.70 -.12 1.17  * 
physical role -.23 1.49 ** -.17 1.31 .05 1.37 ** -.71 1.79 -.14 1.52 .24 0.56   
bodily pain  .51 1.05 ** .66 0.95 ** .63 1.13 ** .63 1.10 -.14 1.10 .28 0.97  ** 
general health .00 1.38 .01 1.27 .59 1.30 ** -.40 1.41 -.94 1.68 .30 1.10  * 
PCS .33 1.30 ** .22 1.36 .84 0.98 ** .14 1.57 -.24 1.15 .56 1.09  
vitality -.16 1.23 .12 1.25 -.25 1.15 -.33 1.00 -.56 1.44 -.29 1.07   
social function -.21 1.22 -.01 1.05 -.05 1.09 -.14 1.06 -.24 1.25 -.51 0.90   
emotional role -.52 1.52 -.08 1.10 -.63 1.63 -.83 1.82 -.22 1.22 -1.21 1.71  ** 
mental health -.28 1.12 -.09 0.98 -.29 1.04 -.35 1.22 -.43 1.13 -.24 1.13   
MCS -.42 1.22 -.07 1.07 -.58 1.37 -.56 1.23 -.43 .92 -.80 1.36  
BSI  T sd  T sd  T sd  T sd  T sd  T sd   
somatization 50.68 10.76 49.68 10.44 48.54 8.39 49.92 10.83 54.60 11.67 52.89 11.46  
obsessive-compulsive  52.98 12.35 * 49.91 11.49 53.15 11.60 54.54 12.26 53.10 12.60 57.11 10.13  
interpersonal sensitivity 53.99 11.72 ** 50.98 9.92 57.31 12.36 * 51.23 9.36 53.90 10.40 55.33 12.42  
depression 54.79 11.84 ** 52.54 11.26 54.61 11.31 53.69 8.16 60.00 11.24 * 53.22 13.40  
anxiety 52.81 10.84 * 50.31 11.55 54.27 10.73 52.31 6.54 54.60 9.52 53.89 9.85  
hostility 56.10 11.52 ** 53.90 9.91 * 56.88 13.82 * 57.15 11.82 54.80 9.60 60.11 6.33 **  
phobic anxiety 50.56 9.05 48.75 8.70 51.46 9.88 50.31 7.98 50.40 7.17 52.56 7.54 ** 
paranoid ideation 54.75 11.37 ** 54.30 11.54 * 53.84 12.09 51.46 6.38 54.80 9.47 54.44 9.77  
psychoticism 54.06 11.63 * 49.72 9.67 55.38 10.89 * 52.69 9.49 57.60 12.43 58.22 12.37 * ** 
GSI 54.39 13.54 ** 51.48 12.40 54.61 14.35 53.77 9.18 57.20 11.78 58.22 10.53  
PST 54.79 12.04 ** 51.37 10.74 55.92 13.38 53.38 8.13 56.60 10.17 57.67 10.48  
PSD 53.45 12.46 ** 51.93 12.39 53.00 12.08 52.00 9.35 54.40 11.75 57.56 9.30 *  
Clinical cases  47 (42.7%)  14 (31.8%)  12 (46.2%)  7 (53.8%)  4 (40. 0%)  5 (55.6%)   
¹Including single case descriptions; p values are calculated with the nonparametric Wilcoxon signed rank test z equals 0.00 and T equals 50.00;  p≤ .05* and p≤.01**; SF-36: 
Higher scores indicate a higher HRQOL z=0 is the mean of the norm; (sd=1); BSI: higher scores indicate a higher level of psychological distress T=50 mean of the norm 
(sd=10); significant better outcome then the norm are marked bold; significant impaired outcome then the norm are marked italic and bold. Abbreviations: PCS: physical 





Figure II.1 Comparison of physical and mental HRQoL   
 
PCS: physical component summary, MCS: mental component summary; 
Higher scores indicate a higher HRQoL; z=0 is the mean of the norm; 
(sd=1) 
Discussion 
In this study, a considerable difference between psychological and physical wellbeing was 
identified in a cohort of 110 adults with various DSD conditions. Participants reported 
overall higher physical HRQoL, normal mental HRQoL but high psychological distress 
(42.7%) measured by SF-36 and BSI accordingly. 
Health-related quality of life  
Within HRQoL a difference between physical HRQoL and mental HRQoL was identified 
(Figure II.1). Participants rated their physical HRQoL higher than the norm and their mental 
HRQoL similar to the norm. However, most participants showed rather low mental HRQOL, 
which failed to reach significance. This might be due to the inhomogeneous group 
distribution, larger variation and non-normal distribution of the data. Using a different 
questionnaire (WHOQOL-BREF, WHOQOL), other studies described the same effect 
(D'Alberton et al., 2015; Wang & Tian, 2015). Likewise, previous analysis of the German 
DSD network study of adolescents with DSD reared as girls showed higher HRQoL scores 
than girls of the reference group regarding physical wellbeing. The authors suggested two 
possible explanations of this finding: On one hand exposure to high prenatal androgens has 
a long-lasting positive effect on the girls’ physical wellbeing lasting until adolescence. On the 
other, unlike girls who experience typical female puberty changes, girls with DSD are not 
exposed to hormonal fluctuations of the sex hormones (Kleinemeier, Jurgensen, et al., 
2010). Both explanations may apply to adult females as well and could explain why 
participants within the group f-XY-pa reported higher physical HRQoL as compared to the 
other groups.  
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In contrast, a previous study of adults with DSD conditions in Brazil found that males 
reported a significantly better QoL when compared to females. In group comparisons, males 
of our study with XY DSD (m-XY-pa) reported the lowest HRQoL (Amaral, Inacio, Brito, 
Bachega, Oliveira, et al., 2015). Cultural differences might be the cause of these varying 
results but overall data on QoL of males with XY DSD conditions are still scarce. When 
compared to previous studies also using the SF-36 in adults with CAH, the group f-CAH-pa 
in this study showed a better HRQoL (Table II.5a).  
Another study from Germany showed similar results as our study, in that they did not differ 
from the controls. The authors concluded that good HRQoL can be achieved when 
individuals with CAH are under tight endocrine specialist observation starting in early 
childhood (Reisch et al., 2011). This applies to participants of our study as well, as they were 
recruited mainly from tertiary centres. Other than CAH, the SF-36 has not been used in 
previous studies analysing HRQoL for individuals with DSD conditions. Currently, there are 
several studies indicating normal QoL in individuals with DSD (Table II.5b). These studies 
show that individuals with DSD are able to cope well with their conditions. However, 
methodological problems like different samples, various measurements and selection bias 
prevent generalizability (Amaral, Inacio, Brito, Bachega, Domenice, et al., 2015; 
Nordenstrom, 2015; Schützmann et al., 2009; Wisniewski & Mazur, 2009; Zainuddin et al., 
2013). Especially selection bias might affect results, as individuals are recruited via multiple 
strategies and not all individuals invited chose to participate. There are studies in which 39-
47% of the invited participants chose not to participate (D'Alberton et al., 2015; Fagerholm 
et al., 2012). These individuals may have refused to participate due to impaired wellbeing. 
Authors of studies in which the cohort indicated normal QoL suggest that this outcome may 
be attributable to proper treatment, including regular follow-ups and psychological support 
(Wang & Tian, 2015). The authors of one study highlight that the participants were followed 
in the same tertiary referral centre by a multidisciplinary team including psychological 
support. In this study the mean period of psychological support was approximately 7 years 
(Amaral, Inacio, Brito, Bachega, Oliveira, et al., 2015). It seems likely that this extensive 
support has resulted in good QoL. In our study, HRQoL was associated with satisfaction with 
care as described in our previous analysis of the health care situation of this cohort (Thyen 







Table II.5: Literature Review  
Table II.5a: HRQoL in CAH with SF-36 
Study Country N Condition Questionnaire Result  
Nermoen, Husebye, 




CAH (39 males; 65 females) SF-36 HRQoL was significantly impaired across all eight domains. 
No difference between the salt wasting and simple virizing 
form of CAH. Working disability was reported by 19% of the 
patients. 
Arlt et al. (2010) 
respectively* 
Han, Walker, Arlt, 
and Ross (2014)  
 
UK 
N= 203  
respectively 
N=151 
CAH (65 males; 138 females)  
 
CAH (50 males; 101 females) 
SF-36 HRQoL was impaired across all eight domains.  
QoL scores were associated with type of glucocorticoid 
treatment. QoL was not related to PreDEq (prednisolone dose 
equivalent) or mutation severity. Increased adiposity, insulin 
resistance and use of prednisolone or dexamethasone are 
associated with impaired QoL. 




CAH (36 males; 45 females) SF-36 HRQoL scores did not differ from controls. 
Participants had impaired HRQoL in three of five GBB-24 
scores whereas SF-36 and HADS scores did not differ from 
controls. 
This study Germany n= 44 CAH (females) SF-36 Overall HRQoL scores did not differ from controls. HRQoL in the subscale bodily pain was better than the norm. 
No difference between the salt wasting and simple virilising 







Table II.5b: Latest quantitative studies evaluating QoL in adults with various DSD conditions 
Study Country N Condition Questionnaire Result  
Fagerholm, Mattila, Roine, 
Sintonen, and Taskinen 
(2012)  








QoL and HRQoL scores appeared normal in most of 
the participants. 
Amaral, Inacio, Brito, 
Bachega, Oliveira, et al. 
(2015)  
Brazil N= 144 56 CAH (49 females, 7 male) 
26 AIS (19 female, 7 male)  
25 GD (13 female, 12 male) 
16 5a-RD 2 deficiency (6 female, 10 male) 
10 17b- HSD3 deficiency (6 female, 4 male) 
11 other conditions (10 female, 1 male) 
WHOQOL-Bref  • QoL was comparable to the general population. 
• The chronological age at the start of treatment was 
significantly associated with general QoL score. 
• Among the 46,XY DSD group, the male social sex 
patients had better QoL compared with the female 
social sex participants. 
Wang and Tian (2015)  China N=87 16 CAH,  
22 AIS 
22 GD  
23 Turner syndrome,  
4 other conditions  
(all female) 
WHOQOL-Bref No significant difference between DSD patients and 
general population. 
The scores of psychological and environmental 
domains were lower than that of the physical and 
social relationship domains, but the difference was not 
significant.  
D'Alberton et al. (2015) Italy N=43 34 AIS 
1 GD  
4 5α-reductase deficiency,  
4 other conditions 
(all female) 
WHOQOL • Normal QoL, even though participants showed higher 
degree of psychological distress than the comparison 
group. Less satisfied in psychological and social areas. 
Younger persons living with a 46,XY DSD showed 
better psychosocial adjustment than older ones. 
de Neve-Enthoven et al. 
(2016) 
Netherlands N=120 42 CAH (41 female, 1 male) 
29 AIS (27 female, 2 male) 
25 GD (22 female, 3 male) 
24 other conditions (15 female, 9 male) 
TNO-AZL Quality of 
Life questionnaire 
(TAAQOL) 
• Individuals across all diagnostic groups generally 
reported a good psychosocial well-being. 
This study Germany N=110 46 CAH (44 female, 2 male) 
20 AIS (15 female, 1 male, 4 other gender) 
25 GD (19 female, 3 male, 3 other gender) 
19 other conditions (11 female, 6 male, 2 
other gender) 
SF-36 • Higher physical HRQoL and normal mental HRQoL 
compared to the population reference data.  
• Higher scores in the subscale bodily pain and lower 









Table II.5c: Previous studies evaluation psychological wellbeing in persons with various DSD condition using similar Questionnaire 





Germany N=37 11 CAH (female) 
26 other conditions (23 females, 3 males) 
BSI Overall higher psychological distress compared to the 
norm population. 59% can be classified as clinical case 
according to predefined BSI criteria. 
Johannsen, Ripa, 
Mortensen, and Main 
(2006) 
Denmark N=70 40 CAH  
11 cAIS 
3 GD 
16 other conditions 
 (all female) 
SCL-90 The total SCL-90 score was higher in participants with 
DSD than in controls, reaching significance for anxiety 
with highest score in females with CAH.  
Fagerholm et al. (2012) Finland N=24 16 CAH 
8 AIS  
(all female) 
SCL-90 Similar psychological distress compared to a community 
sample.  
This study Germany N=110 46 CAH (46,XX, 44 females, 2 males) 
20 AIS (15 females, 1 male, 4 other gender) 
25 GD (19 females, 3 male, 3 other gender) 
19 other conditions (11 females, 6 males, 2 
other gender) 
BSI • High psychological distress compared to the norm 
population. 42.7% of the participants can be described as 
a clinical case due to BSI criteria. 
*Both studies use data form the Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE); Abbreviations: CAH: congenital adrenal hyperplasia, AIS - androgen 
insensitivity syndrome, GD: gonadal dysgenesis SCL-90: Symptom-Checklist-90 (long version of the BSI) 
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Psychological wellbeing – BSI 
The high psychological distress of participants in this study is in line with previous studies 
(D'Alberton et al., 2015; Engberg et al., 2015; Johannsen et al., 2006; Schützmann et al., 
2009). An overview of findings from our and other studies using the BSI or the SCL-90 to 
describe psychological wellbeing is presented in Table II.5c. In contrast to the only study 
using the BSI the number of clinical cases of our study was lower (59% versus 42.7%) 
(Schützmann et al., 2009). Psychological wellbeing differs in the two studies, although both 
were performed in the same period in Germany using the same instruments. The authors of 
the other German study described a potential selection bias as the study was conducted by 
an institute of Institute for Sex Research and Forensic Psychiatry and may have attracted 
persons with DSD who were more psychologically distressed (Schützmann et al., 2009). On 
the other hand, also a selection bias of our study could explain the different results as 
participants were predominately invited through their hospital and physicians (Thyen et al., 
2014). Moreover, physicians could have avoided informing severely distressed patients. The 
cases criteria on the BSI can be used as a selection criterion for those individuals who would 
require further formal mental health assessment; therefore, the definition does not indicate 
mental disease but the presence of subjective impairment (Kellett, Beail, Newman, & 
Frankish, 2003). Our results demonstrate that adults with DSD are markedly psychologically 
distressed and care should focus more on psychological wellbeing in addition to physical 
aspects. It was recommended only in 2005 that psychological support should be part of 
multidisciplinary care of individuals with DSD (Lee et al., 2006). As the participants of this 
study were recruited from 2005 to 2007, they mostly could not benefit from professional 
psychological support as it was only offered to 31 % of the cohort (Thyen et al., 2014). 
However, it seems that psychological support is still not sufficient in patients with DSD 
conditions, as also recent studies of younger individuals with DSD showed significant 
impaired psychological outcome (D'Alberton et al., 2015; de Neve-Enthoven et al., 2016). 
Other gender  
In this study, nine participants (8.2%) describe themselves as a gender other than male or 
female. They rated their HRQoL and psychological distress as similar to the rest of the cohort. 
This observation indicated that identification with a gender outside or overriding male or 
female dichotomy is not associated with impaired QoL or psychological distress. It could be 
a way of coping with the feelings of gender ambiguity. 
Schweizer et al. (2013) described that 7% of their cohort reported gender roles other than 
male or female, and 3% reported a neither female nor male gender identity. Three of the 
participants with other gender in our cohort have the condition cAIS. Our result is 
concordant to the findings of Brunner et al. (2016), in which 5 out of 11 participants with 
cAIS chose the gender/sex category of other. However, an overlap of participants might be 
possible as they are both German studies. These results are different to previous studies, in 
which female gender identity and role was established and maintained in all individuals 
diagnosed with cAIS (Mazur, 2005). An explanation might be that out of the 9 individuals, 
8 declaring other gender were member of a DSD association or support group. In the other 
groups, such as the f-CAH-pa and m-XY-pa group, only a minority are members of a DSD 
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association or support group. Being a member of a support group might explain the 
declaration of another gender as these participants had more information and broader 
understanding of sex and gender. Otherwise, it could also be, that individuals not identifying 
as male or female might be more prone to participate in DSD associations. The results of this 
subgroup serve to show that feeling neither clearly male nor female does not necessary 
inhibit good HRQoL and psychological wellbeing, even though some challenging experiences 
in a dichotomous society might appear.  
Limitations 
A potential for selection bias and social desirability bias limits the generalizability of our 
results. Comparisons to the norm are limited as available German norm data for the SF-36 
are from 1998 and from 2000 for the BSI, while the cohort was recruited from 2005 to 2007. 
Potential difference within and between these groups and the norm may not be significant 
due to small sample size of the different groups. Quality criteria and factor structure of the 
BSI have been criticized (Franke, 2000; Skeem et al., 2006). Beside general scepticism on 
the concept of QoL there is specific doubt on the reliability of the SF-36 (Pukrop, 2003). 
Additionally, the SF-36 measures limitations in QoL but it fails to identify the subjective 
importance of these limitations for the individual (Bullinger, 2000). Moreover, it should be 
noted that although it seems to be a positive outcome, if QoL of individuals with DSD does 
not differ from the norm, one must take into account that the goal of treatment should be to 
provide the best possible health status, not a health status similar to the norm population.  
Conclusion		
We found a trend of lowered mental HRQoL and significant higher physical HRQoL for 
participants as compared to a norm. Group comparison leads to the hypothesis that females 
with XY DSD might profit from an early effect of androgens, thus contributing to positive 
physical HRQoL. Although there is a high physical HRQoL participants reported significant 
impaired psychological wellbeing, 42.7% can be described as a clinical case. Impaired 
psychological wellbeing is an unfortunate outcome in many persons with DSD conditions 
and we conclude that specialized interdisciplinary care with a focus in particular on 
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Differences/ disorders of sex development (DSD) is an umbrella term for congenital 
conditions often diagnosed within childhood. As most parents are unprepared for this 
situation psychological support (PsySupp) is recommended. The aim of this study was to 
analyse the extent to which parents express a need for PsySupp. 329 parents of children with 
DSD were included. 40.4% of the parents indicated to have a need for PsySupp, only 50% 
of this group received it adequately. The diagnoses partial gonadal dysgenesis, partial 
androgen insensitivity syndrome (pAIS) and disorders of androgen synthesis are associated 
with a high need for PsySupp in parents (54%, 65%, 50%). Sex assignment surgery neither 
reduced nor increased the need for PsySupp. Taking a picture, radiography, laparoscopy, 
gonadal biopsy, gonadectomy and hormonal puberty induction are associated with a high 
need for PsySupp. There was no association between the need for PsySupp and the parents’ 
perception of the appearance of the genitalia. Conclusion: Having a child with DSD is 
associated with a high need for PsySupp in parents. In particular, parents of children with 
XY-DSD with androgen effects other than hypospadias expressed a high need of PsySupp. 
PsySupp for parents should be an obligatory part of interdisciplinary care to reduce fears and 
concerns.  
Introduction 
“Differences/ disorders of sex development” (DSD) is an umbrella term for rare congenital 
conditions with incongruence between chromosomal, gonadal and phenotypic sex. DSD 
include conditions with diverse genetic aetiology, varying levels of prenatal androgen effects 
and phenotypes of genitalia and subsequent different medical treatments (Jürgensen et al., 
2010). The term “DSD” was introduced 2005 by the Chicago DSD Consensus Group on 
management of intersex condition to replace nomenclature such as “intersexuality” 
“hermaphroditism” or “testicular feminization” (Lee et al., 2006). According to the Chicago 
DSD Consensus Group, DSD conditions are classified depending on the karyotype and 
pathogenesis in 3 groups: sex chromosome DSD, XY DSD and XX DSD. Sex chromosome DSD 
include mixed gonadal dysgenesis (46, XY/45, XO), 46XY/46 XX conditions, Turner and 
Klinefelter syndrome. 46,XY DSD encompass XY gonadal dysgenesis, androgen insensitivity 
syndrome (AIS), disorders of androgen synthesis and severe hypospadias. 46,XX DSD 
comprises congenital adrenal hyperplasia (CAH), XX gonadal dysgenesis and uterine and 
vaginal anomalies. Most parents are unprepared for this complex and challenging situation 
which can cause confusion, emotional stress, anxiety and perhaps feelings of guilt and shame 
(Lev, 2006; Medeiros Rocha Santos & Cavalcanti Ferreira de Araujo, 2008; Sandberg, 
Gardner, & Cohen-Kettenis, 2012). Gough et al. (2008) highlighted the fundamental shock 
engendered by the uncertain sex status of children and document parental struggles to 
negotiate a coherent sex identity for their children. Two recent studies revealed that parents 
reported overall levels of post-traumatic stress (PTSS) that was comparable to those reported 
by parents of children diagnosed with cancer (Hullmann, Fedele, Wolfe-Christensen, 
Mullins, & Wisniewski, 2011; Pasterski, Mastroyannopoulou, Wright, Zucker, & Hughes, 
2014). Moreover another study showed that parents of children with CAH demonstrated 
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symptoms of depression that did not abate with the passage of time (de Silva, de Zoysa, 
Dilanka, & Dissanayake, 2014).  
The reaction of parents to the birth of a child with DSD has crucial effects on the atmosphere 
in which the parent-child relationship will develop. Parents who also experience caring, 
accepting and encouraging support from the medical and psychological staff are more likely 
to be able to develop these attitudes towards their child (Richter-Appelt, 2012). An 
atmosphere of uncertainty, fear and denial hampers this development (Richter-Appelt, 
2013). Subsequently, DSD of a child can have an impact on the dynamic of the parent-child 
relationships, the parental and family relationships (Hullmann et al., 2011; Richter-Appelt, 
Brinkmann, & Schützmann, 2006; Schober et al., 2012). The uncertainty, if a decision on 
the gender of rearing is needed, is especially likely to increase parental stress (Jürgensen et 
al., 2006). Atypical gender role behaviour and gender dysphoria in childhood and 
adolescence may foster the need for PsySupp in parents.  
It has been recommended by the Chicago DSD Consensus Group and the German Ethical 
Committee (Deutscher Ethikrat, 2012; Lee et al., 2006) that interdisciplinary care of DSD 
should include a psychologist. On the one hand, the psychologists act as educators and 
counsellors regarding the psychological aspects of DSD. On the other, they have a unique 
position among all team members facilitating the group process within the team and between 
the team and family (Sandberg et al., 2012). The appropriate counselling of parents and 
family starting at diagnosis is needed in order to achieve the best possible development and 
quality of life of children and adolescents with DSD (Hiort, 2012; Moran & Karkazis, 2012). 
This study is a part of the German clinical evaluation study investigating the clinical 
outcomes and health care situation of individuals with DSD from 2005-2007 (Lux et al., 
2009). The aim of this study is to analyse the extent to which parents of children with DSD 
express a need for PsySupp. To further improve clinical care, factors which are associated 
with a greater need for PsySupp in parents should be identified. 
Methods 
Study design  
The multicentre clinical evaluation study was part of the German network of DSD, funded 
by the German Ministry of Education and Science (BMBF) (Lux et al., 2009). The aim of the 
study was to describe the clinical outcomes and health-care situation in individuals with 
DSD. Recruitment took place at four study centres in Germany and at five sites in Austria 
and Switzerland between January 2005 and December 2007. A psychosocial inquiry of 
children, adolescents and adults with DSD and their parents was performed. Inclusion 
criteria of the study followed a generic definition of DSD with laboratory-confirmed 
diagnosis or clinical diagnosis by a physician. Individuals with Klinefelter or Ullrich-Turner 
syndrome, severe psychiatric comorbidity and mental disabilities were excluded. Only 
diagnoses which were formerly known as “intersexuality” and CAH were included. The 
assessment of the participants and their parents was conducted by trained psychologists 
during personal encounters. All participants and their parents gave written informed consent 
for participation and release of medical data to the interviewer and the principal investigator. 
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A total of 439 children and adolescents, their parents and adults with DSD participated (Lux 
et al., 2009).  
Instruments  
The study design of the multicentre clinical evaluation study has been described previously 
(Lux et al., 2009). For the substudy the “DSD-questionnaire” was used: a questionnaire for 
parents of children with DSD which was developed after consulting experts in the field and 
reviewing the literature. The DSD-questionnaires included socio-demographic variables, 
questions about medical history, child development, peer relations, and questions 
concerning DSD (e.g. gender change, knowledge about diagnosis) (Jürgensen et al., 2010). 
Beside the DSD-questionnaire parents were asked to fill out the Child Behaviour and 
Attitudes Questionnaire (CBAQ) (Meyer-Bahlburg, Sandberg, Yager, Dolezal, & Ehrhardt, 
1994). The questionnaire allows for calculating on two scales. The Femininity Scale 
measuring the extent of typical feminine behaviour (bipolar; high scores = feminine) and 
the Cross-Gender-Scale measuring the extent of cross-gender behaviour (unipolar; high 
scores = more cross-gender behaviour) (Jürgensen et al., 2010).  
The need for PsySupp in parents was assessed within the DSD-questionnaire: “Please indicate 
if you have received psychological counselling/ psychotherapy”. The three categories of 
response which are related to need for PsySupp in parents were: “We have received 
psychological counselling/ psychotherapy”, “We have received psychological counselling/ 
psychotherapy partly”, “We have not received, but we would needed psychological counselling/ 
psychotherapy”. The answer category “We have not received, and we do not need psychological 
counselling/ psychotherapy” is associated with no need for PsySupp in parents.  
Variables that could be related to the need of the parents were selected based on the content 
from the remaining pool of items and exploratory data analysis was undertaken.  
Diagnoses of children and adolescents were classified into DSD-XX or XY without (c) or with 
partial (p) androgen effects, and female (f) or male (m) sex of rearing: DSD-XX-p-f, DSD-
XY-p-f, DSD-XY-p-m, DSD-XY-c-f. The evaluation was performed on basis of the total cohort 
and between the diagnostic groups.  
Statistical analysis  
For all analyses, SPSS version 22 statistical software was used. The χ² test (2-sided) or, if 
necessary, the Fisher’s Exact Test and t-test for independent samples were used to measure 






Caregivers of 329 children and adolescents with DSD (mean age 7.25 years; SD 4.96) 
participated (Table III.1). In 125 cases both parents together, in 185 the mothers, in 14 the 
fathers and in 4 cases other caregivers answered the questionnaire. In one case no data as 
to which caregiver completed the questionnaire was available. Diagnoses of children and 
adolescents were classified in four diagnostic groups (DSD-XX-p-f, DSD-XY-p-f, DSD-XY-p-
m, DSD-XY-c-f) (Table III.2) (Lux et al., 2009).  
Table III.1: Age, nationality, education level of the parents 
 Mothers Fathers 
Total (n) 315 278 
Mean age (SD; range) 37.3 (6.3; 22-57) 40.0 (6.9; 20-62) 
Nationality   
German 253 249 
Austrian 17 18 
Swiss 19 19 
Two nationalities 2 2 
other 36 31 
Total (n) 327 319 
Education level   
Secondary school qualification  
(without higher education entrance 
qualification) 
169 150 
Secondary school qualification  
(with higher education entrance 
qualification) 
57 46 
University degree 82 94 
*Total (n) 308 290 
*Total numbers are unequal due to missing answers. 
 
Need for PsySupp 
128 parents (40.4%) parents indicated to have a need for PsySupp. 189 parents (59.6%) 
reported having no need for PsySupp (Table III.3). The need for PsySupp could not be 
assessed in 12 parents. 
Diagnoses  
There was a significant association between the need for PsySupp and the diagnostic groups 
(p=0.010). The need for PsySupp was highest in the group of parents with the child’s 
diagnosis of DSD-XY-p-f (58.7%). There was a significant association (p=0.025) between 
the need of PsySupp and the most common diagnoses such as partial/mixed gonadal 
dysgenesis (54.2%), pAIS (65%) and disorders of androgen synthesis (50%) included in 
DSD-XY-p-f. The need for PsySupp was lowest in parents of children with CAH (33.9%) or 









Table III.2: Description of the cohort: diagnostic groups, diagnoses and age of the children and adolescents with DSD  
Group DSD-XX-p-f 
n = 132 
DSD-XY-p-f 
n = 66 
DSD-XY-p-m 
  n = 108 
DSD-XY-c-f 
n =22 
Definition female gender of rearing with 
46,XX DSD and androgen effects 
female gender of rearing with 
46,XY DSD or mocaicism and 
partial androgen effects 
male gender of rearing with 46,XY 
DSD or mocaicism and partial 
androgen effects 
female gender of rearing with 
46,XY DSD without androgen 
effects 
Karyotype XX XY+ XY+ XY 
Gender of rearing female female male female 
Androgen effects present present present none 
Condition     
AIS  - 12 pAIS 9 pAIS 12 cAIS 
Gonadal dysgenesis 1 partial/mixed gonadal 
dysgenesis 
29 partial/mixed gonadal 
dysgenesis 
21 partial/mixed gonadal 





dehydrogenase III deficiency (7), 
5 alpha-reductase II deficiency 
(4), LH-receptor defect (1), 
17/20-Lyase deficiency (1) 
5alpha-reductase II deficiency (3), 
LH-receptor defect (3), 17beta 
hydroxysteroid-dehydrogenase III 
deficiency (2), not precisely 
classified (2) 
- 
CAH CAH (128) - - - 
Severe hypospadias - severe hypospadias (1) severe hypospadias (50) - 
Other conditions 
complex malformation (1), 
aromatase deficiency (2), 
complex malformation (5), penile 
agenesis (1), cloacal exstrophy 
(1), unclassified clinical diagnoses 
of DSD (4) 
 
disorder of anti-mullerian 
hormone (1), Complex 
malformation (3), 46, XX-
male*(3), micropenis (2), 
unclassified clinical diagnoses of 
DSD (9) 
clinically most likely SF1 
mutation, but defect was not 
found (1) 
Age     
Newborns 8 4 10 1 
6 months – 3 years 29 7 36 1 
4 – 7 years 29 12 34 5 
8 – 12 years 33 24 21 8 
13 – 16 years 33 19 7 7 
AIS= androgen insensitivity syndrome: CAH= congenital adrenal hyperplasia, cAIS= complete androgen insensitivity syndrome, DSD= disorders/diversity of sex development, pAIS= partial 
androgen insensitivity syndrome.+ incl. mosaics with parts of „Y chromosome" (in some cases chromosome status has not been investigated, in these cases classification results according to the 




Table III.3: Need for PsySupp in parents (N=317) 
 n % 
Need for PsySupp 128 40.4 
Divided in: “We have received psychological counselling/ psychotherapy” 29 (22.7) 
 “We have received psychological counselling/ psychotherapy partly” 32 (25.0) 
 “We have not received but we needed psychological counselling/ 
psychotherapy” 
67 (52.3) 
No need for PsySupp 
“We have not received, and we do not need psychological counselling/ psychotherapy” 
189 59.6 
 
Table III.4: Significant results of the study 
 Need for PsySupp No need for PsySupp  
 n % n % n 
Total 128 40.4 189 59.6 317 
Diagnostic groups** DSD-XX-p-f 43 33.6 85 66.4 128 
DSD-XY-p-f 37 58.7 26 41.3 63 
DSD-XY-p-m 40 38.5 64 61.5 104 
DSD-XY-c-f 8 38.1 13 61.9 21 
Main conditions* pAIS 13 65.0 7 35.0 20 
cAIS 5 41.7 7 58.3 12 
Partial/mixed gonadal dysgenesis 26 54.2 22 45.8 48 
complete gonadal dysgenesis 3 37.5 5 62.5 8 
Disorders of androgen synthesis 11 50.0 11 50.0 22 
CAH 42 33.9 82 66.1 124 
Severe hypospadias 13 26.5 36 73.5 49 
other 15 44.1 19 55.9 24 
Surgeries Gonadectomy* 36 52.2 33 47.8 69 
Investigations in context of the diagnosis  
Taking a picture** 70 49.0 73 51.0 143 
Radiography* 63 47.7 69 52.3 132 
Laparoscopy** 16 66.7 8 33.3 24 
Gonadal biopsy** 38 56.7 29 43.3 67 
Induction of puberty**      
Hormonal induction of puberty - received 15 50.0 15 50.0 30 
Hormonal induction of puberty - planned 28 58.3 20 41.7 48 
No hormonal introduction of puberty 63 35.0 117 65.0 180 
Nationality of the father**      
German. Austrian. Swiss. two nationalities 105 37.6 174 62.4 279 
other 19 65.5 10 34.5 29 
Education level of the mother*      
Secondary school qualification (without 
higher education entrance qualification) 69 61.7 93 57.4 162 
Secondary school qualification (with higher 
education entrance qualification) 14 25.0 42 75.0 56 
University degree 37 47.4 41 52.6 78 
Occupation of the father***      
Full-time work 89 35.6 161 64.4 250 
Part-time work 8 53.3 7 46.7 15 
Unemployed 10 71.4 4 28.6 14 
Retired 6 85.7 1 14.3 7 




Parents’ perception of the appearance of the genitalia, gender of rearing and gender 
role behaviour 
No significant association could be found between the need for PsySupp of parents and their 
perception of the genitalia of the child at birth and gender of rearing (Table III.5). A change 
of the gender of rearing was performed in 32 children of the diagnostic groups DSD-XX-p-f 
(male to female n=15; diagnosis CAH; mean age of change of gender of rearing 0.30 years), 
DSD-XY-p-f (male to female n=9; diagnoses: partial gonadal dysgenesis n=6; PAIS n=2; 
other n=1; mean age of change of gender of rearing 0.72 years) and DSD-XY-p-m (female 
to male n=8; diagnoses: partial gonadal dysgenesis n=2; severe hypospadias n=2; other 
n=4; mean age of change of gender of rearing 0.84 years). The gender change was initiated 
by doctors in 19 cases (mean age 0.37 years) and by parents in 9 cases (mean age 1.01 
years). There was no second change of the gender of rearing in the sample. 16 parents 
(53.3%) reported a need for PsySupp if there was a change of the gender of rearing 
(p=0.171). There was an association of need for PsySupp in parents and preferred gender 
of playmates of the child in the diagnostic group DSD-XX-p-f (p=0.038). There was a high 
need for PsySupp if the children preferred to play with boys (81.8%) or girls (64.0%). There 
was a low need for PsySupp in parents if the children preferred to play with both genders 
(37.5%) (Table III.6). This was not the case in the other diagnostic groups. Although not 
significant due to small sample size, a difference may also apply to the diagnostic group DSD-
XY-p-m.  
Gender role behaviour measured with the CBAQ (Jürgensen et al., 2010; Jürgensen et al., 
2014) was also associated with need for PsySupp in parents of children within the diagnostic 
group DSD-XY-p-f. There was a higher need for PsySupp when the parents indicated that 
their child showed more cross gender behaviour (Table III.7). This was not case in the other 
diagnostic groups. 





























DSD-XX-p-f 37 15 (40.5) 25   8 (32.0) 42 13 (31.0) 4 2 
DSD-XY-p-f* 25 16 (64.0) 11   9 (81.8) 16   6 (37.5) 2 - 
DSD-XY-p-m 7   5 (71.4) 35 13 (37.1) 37 13 (35.1) 3 - 
DSD-XY-c-f 13   4 (30.8) 1 - 6   3 (50.0) - - 
Total 82 40 (48.8) 72 30 (41.7) 102 35 (34.3) 9 3  
*significant p≤0.05 
“How did you assess your 
child’s genitalia 
immediately after birth?” 
male ambiguous female 
n 
Need for 




n (%) n 
Need for 
PsySupp  n 
(%) 
DSD-XX-p-f 30 13 (43.3) 34 9 (26.5) 57 16 (28.0) 
DSD-XY-p-f 8 5 (62.5) 14 8 (57.1) 40 24 (60.0) 
DSD-XY-p-m 72 24 (33.3) 19 8 (42.1) 6 9 (66,7) 
DSD-XY-c-f 0  0  21 8 (38.1) 
Total 110 42 (38.2) 67 25 (37.3) 127 54 (42.5) 
Not significant        
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Table III.7: CBAQ and need for PsySupp in parents; diagnostic group DSD-xy-p-f  
 Need for PsySupp No need for PsySupp 
N (%) 21 (65.6) 11 (34.4) 
Femininity scale** 
Mean (SD) 
63.3 (8.8) 72.6 (7.5) 
Cross-gender scale*** 
Mean (SD) 
26.6 (7.6) 18.4 (4.1) 
Femininity Scale measuring the extent of typical feminine behaviour (bipolar; high scores = 
feminine); Cross-Gender-Scale measuring the extent of cross-gender behaviour (unipolar; high 
scores = more cross-gender behaviour); only significant results are stated:  **p≤0.01; ***p≤0.001 
Surgery, medical investigations and hormonal treatment 
No association between the need for PsySupp in parents and genital reconstructive surgery 
could be found. Genital reconstructive surgeries were: female urethral correction (n=27, 
scheduled in n=7), male urethral correction (n=67, scheduled in n=18), vaginoplasty 
(n=84 scheduled in n=41), feminizing surgery of the clitoris (n=102, scheduled in n=12), 
vaginal dilation (n=11, scheduled in n=13), testicular relocation (n=38 scheduled in n=10) 
and masculinisation surgery of the penis (n=59 scheduled in n=16). 270 (82%) parents 
(117 DSD-XX-p-f; 49 DSD-XY-p-f; 98 DSD-XY-p-m; 6 DSD-XY-c-f) indicated that genital 
surgery of the child was recommended. No association between the need for PsySupp in 
parents and recommended genital surgery could be found. In our sample, parents reported 
different previous medical procedures. An association (p=0.027) between gonadectomy 
(n=72, scheduled in n=9) and need for PsySupp in parents could be found (Table III.4). 
Parents reported various medical investigations in the context of their child’s diagnosis. 
There was a significant association between need for PsySupp in parents and medical 
investigations such as taking a photo (p=0.006), radiography (p=0.028), laparoscopy 
(p=0.009), gonadal biopsy (p=0.003) (Table III.4). No association to need for PsySupp was 
found for blood sampling (n=285), magnetic resonance imaging (MRI; n=23), 
computerised tomography (CT; n=18), endoscopy (n=43) or ultrasound (n=249). An 
association between need for PsySupp in parents and previous or planned hormonal 
induction of puberty could be found (p=0.01) (Table III.4).  
Understanding of the diagnosis 
119 (40.9%) parents reported that they did not completely understand the information 
about the final diagnosis. 172 (59.1%) parents reported that they did understand the 
information. No association between the need for PsySupp and understanding the diagnosis 
could be found. 
Age at diagnosis, duration of making the diagnosis and sources of information 
No significant association with the need for PsySupp of parents could be found for: the age 
at first diagnosis (in 26 cases the diagnosis was confirmed before birth, in 240 cases in the 
first 5 days after birth, in 39 cases in the first year and in 24 cases after one year), the 
duration of making the diagnosis (in 74 cases making the diagnosis took 1-7 days, in 80 
cases 1-4 weeks, in 90 cases 1-12 months and in 20 cases longer than one year); for presence 
of previous case of familial DSD (n=39) and for sources of information. In addition to 
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information about the condition from medical staff, parents used the internet (n=177) books 
(n=107) and/or information from self-help groups (n=104). 
Sociodemographics 
Significant associations between need for PsySupp in parents and nationality of the father 
(p=0.005), level of education of the mothers (p=0.024) and unemployment of the father 
(p=0.001) could be found (Table III.4). No significant association could be found between 
the need of PsySupp and who responded the questionnaire, age of the parents, age of the 
child, importance of religion, persuasion, size of the hometown and number of siblings. 
Free comments of the parents 
In addition to the quantitative questions, the parents could express their views and opinions 
as free comments. Some qualitative impressions of desires and needs of the parents with 
need for PsySupp were: “I needed somebody giving me confidence and information”, “in the 
first years I strongly desired psychological care”, “Open conversation with hospital staff”, 
“Psychological guidance for the development of my child”, “psychological support at diagnosis 
immediately after birth“, „contact and exchange with other parents”, “That I was perceived”, 
“someone who encourages me and stands by me during the period of uncertainty immediately 
after birth and in the first weeks”, “I would like to have a contact person to get some advice for 
upcoming problems and fears in the future”, “Support within the family”, “Counselling about 
the future, puberty; e.g. medical examinations, advice on possible hormonal treatments, possible 
problems and how to be prepared for them”, “to be able to talk about concerns and fears before 
surgery”, “a better comprehension of the physicians”, “during the first surgery I should have had 
help, but I was much too focused on my child to ask” 
Discussion 
The study shows that parents of children with DSD have a high subjective need for PsySupp 
(40.4%). However, only about half of the parents with need for PsySupp received it 
adequately or partly and half needed it but did not receive any PsySupp. We assume that, in 
the 21st century, the services offering professional PsySupp in children’s’ hospitals were not 
well developed in Germany. Leidolf, Curran, Scout, and Bradford (2008) reported that 69% 
of 29 paediatric endocrinology fellowship training offered PsySupp and 58% had a mental 
health specialist on staff, but only 19% of individuals with DSD or families received 
emotional support at diagnosis and only 15% of individuals with DSD or families after 
diagnosis. Pasterski et al. (2010a) found that 95% of centres in Europe treating children with 
DSD in 2010 offered primary psychological support services such as a child psychiatrist or 
psychologist. Moreover, they found that the average uptake of PsySupp services by parents 
of a child with DSD was only 54%, which is higher than the need of for PsySupp in parents 
in this study (40%) (Pasterski et al., 2010a). However, no data are available how often 
PsySupp was offered in this study. Subsequently, potential average uptake cannot be 
evaluated. Although only 40% of the parents indicated a subjective need for PsySupp, a 
higher real need for PsySupp in parents might exist from a psychotherapeutic perspective. 
We assume that fears of stigmatisation by psychotherapy and psychological counselling or 
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ignorance about the benefit, content or aims of the different forms of PsySupp are still factors 
for parents not accepting PsySupp or for physicians not offering it. Additionally, parents 
without offered PsySupp might not be aware of their needs. These studies show that the 
recommendations of the Chicago consensus 2005, to involve a psychologist in the care of a 
child with DSD, have been mostly implemented now in Europe. Thus, parents with need for 
PsySupp have better access to it than before 2005.  
Diagnoses  
The highest need for PsySupp (58.7%) was reported by parents of children with conditions 
included in the diagnostic group DSD-XY-p-f. The diagnoses of partial gonadal dysgenesis, 
partial androgen insensitivity syndrome (pAIS) and disorders of androgen synthesis, which 
are included in the diagnostic group DSD-XY-p-f and DSD-XY-p-m, are particularly associated 
with a high need for PsySupp in parents (54.2%, 65.0%, 50.0%). This high need of PsySupp 
in parents of children with these conditions can be explained by the uncertainties about the 
sex of the child where a decision about the gender of rearing is needed. In contrast, parents 
having a child with severe hypospadias or CAH (46,XX) had much less need for PsySupp 
(33.9%, 26.5%). This difference can be explained by the more consistent assignment to male 
or female gender of rearing. Individuals with CAH (46,XX) are primarily seen as girls and 
individuals with severe hypospadias (46,XY) as boys. This association is not only related to 
the appearance of the external genitalia but also to the internal genitalia and possible future 
fertility. The unambiguity of the gender of rearing reduces uncertainties and confusion and 
apparently simplifies dealing with DSD for parents and for the medical staff because the 
question, “Is it a boy or a girl?” can be answered (Gough et al., 2008).  
Surgery, medical investigations and hormonal treatments 
Our data show that sex-assignment surgery neither reduces nor increases the need for 
PsySupp in parents. Schober (1999a) argues that surgery makes parents and doctors more 
comfortable, but counselling makes people comfortable too, and it is not irreversible (Lev, 
2006). Crissman et al. (2011) point out that immediate surgery reduces early parental 
concerns regarding genital appearance but does not eliminate worries about the child’s 
future gender development or sexual functioning. As surgery does not reduce the need for 
PsySupp in parents, the fears and concerns of parents should not be the reasons for sex 
assignment surgery. It is therefore important to keep in mind that parents want to do the 
“right thing” (Nelson, Caress, Glenny, & Kirk, 2012). Moreover, parental decisions 
concerning early sex assignment surgery depend highly on the medical advice. But neither 
physicians nor parents are fully aware of the magnitude of this medically induced influence 
(Streuli et al., 2013) and may later be burdened with decision regret. 
Investigations in context of the diagnosis such as taking a photo, radiography, laparoscopy 
and gonadal biopsy are associated with a great need for PsySupp in parents (49.0%, 47.7%, 
66.7%, 56.7%). Consequently, only those interventions specifically indicated for further 
treatment planning should be performed. To reduce their stress and concerns, parents should 
always be informed in an adequate and understandable manner about the aims and 
procedures of the different medical investigations. Taking a picture might be associated with 
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need for PsySupp in parents because of stress to them from pointing out the unusual nature 
of the child’s genitalia. Taking a picture should therefore not be undertaken unless absolutely 
necessary for treatment planning. In the medical context, a drawn sketch is often sufficient.  
There was a greater need of PsySupp in parents when gonadectomy of the child was 
performed (52.2%) and if puberty was induced or was planned to be induced hormonally 
(50.0%, 58.3%). Gonadectomy is an irreversible intervention with far-reaching 
consequences for affected individuals as it results in deficiency of own sex hormone 
production and necessitates subsequent lifelong hormone substitution. Therefore, it is 
important that the interdisciplinary team respond to fears and concerns of parents if a 
gonadectomy is planned. Hormonal induction of puberty should be raised and discussed, if 
needed, in the period from childhood to adolescence as, even in early childhood, it can cause 
insecurity in parents.  
Parents’ perception of the appearance of the genitalia, gender of rearing and gender 
role behaviour  
There was no association between parents’ perception of the appearance of the child’s 
external genitalia and need of PsySupp in parents. Duguid et al. (2007) and Pasterski et al. 
(2014) also did not find an association between parental post-traumatic stress, self-esteem, 
psychological stability and genital ambiguity of the child. Therefore, it can be assumed that, 
in the context of the need for PsySupp in parents, the isolated issue of ambiguous genitalia 
plays a minor role. It is more likely that the whole complex situation of having a child of 
uncertain sex and future, without a definite option of “cure”, causes distress for parents.  
Gender-role behaviour and gender specifics in the preferred gender of playmates of the child 
play a role only in the diagnostic group DSD-xy-p-f. In the other groups atypical gender 
behaviour is not associated with need for PsySupp in parents. We assume that this 
association is connected to the uncertainty of gender in this diagnostic group as already 
discussed under diagnoses. As the assignment to a male or female gender of rearing of the 
children is more consistent in the other diagnostic groups, atypical gender behaviour may 
not confuse parents. If children behave atypically, in cases where there was a difficult 
decision on gender of rearing, parents could be insecure with respect to this previous 
decision. This may foster the need for PsySupp in parents.  
Understanding of the diagnoses  
Unexpectedly, there was no association between understanding the diagnoses and the need 
for PsySupp. It can be concluded that, with respect to the need for PsySupp, a precise 
understanding of the DSD condition is not crucial. However, it appears alarming that 41% 
of the parents did not understood the diagnosis completely. This is probably due to the 
complexity of the individual condition, which even for professionals is often difficult to 
understand. Nevertheless, parents and patients should be informed adequately and 




We found no association between the age of the children and need for PsySupp in parents. 
Thus, it can be concluded that PsySupp for parents is relevant from childhood to adulthood. 
Hullmann et al. (2011) confirm that caregivers of children with DSD may have different 
psychosocial needs depending upon their child’s development stage and based upon the 
disorder-related challenges that are salient at that developmental stage. Despite our sample 
not including parents directly at the first suspicion of a DSD condition, it is possible that the 
need for PsySupp in parents is greater at diagnosis than at a later point of time when the 
parents have adapted to the situation (Sandberg et al., 2012). No distinction between the 
maternal and paternal need of PsySupp could be performed as parents answered the 
questionnaire together. Nevertheless, we found associations between maternal and paternal 
sociodemographic data and the parental need for PsySupp. The need for PsySupp was 
greater (>65%) if fathers had non-German citizenship, being part-time employed, 
unemployed or retired. It is likely that fathers of non-German citizenship might have 
problems with understanding the DSD-condition and treatment. Moreover, different cultural 
views of DSD and stigmatisation might be factors inducing increased need of PsySupp in 
these families. In contrast, impaired paternal employment by itself can be a factor for 
increased need of PsySupp for families. Moreover, differences in the need for PsySupp 
related to the maternal education level were found. There was a higher need for parental 
PsySupp when the mother held a university degree. This finding could be explained by a 
higher uptake of PsySupp due to less stigmatisation of psychological counselling in 
academics. In contrast, parents with low maternal education level also had a higher need for 
PsySupp which might be caused by less understanding of DSD and fears of stigmatisation. 
Studies differentiating between maternal and paternal need of PsySupp in DSD are needed 
to verify these differences. Some authors particularly highlighted the need for information 
and education by parents, as DSD is a rare condition and mostly unknown in society (Dayner, 
Lee, & Houk, 2004; Duguid et al., 2007).  
Limitations of the study 
The study was part of a large quantitative cross-sectional outcome study. Consequently, 
neither quantitative data explaining why such a high proportion of parents did not receive 
PsySupp nor on the specific needs for PsySupp of DSD families could be collected. However, 
some qualitative comments of parents were available. Parents expressed the following needs: 
openness, confidence and information, encouragement, advice how to be prepared for possible 
problems in the future, contact and exchange with other parents, possibility of talking about 
fears and concerns before surgery, family support (see results: free comments of the parents). 
Conclusion 
Parents of a child with DSD have a high subjective need for PsySupp, but half of them did 
not receive it as needed. In particular, a high need for PsySupp is indicated for parents of 
children and adolescents with partial or mixed gonadal dysgenesis, pAIS and disorder of 
androgen synthesis (children with XY-DSD with androgen effects). In the last decade, the 
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possibility of receiving PsySupp for families of a child with DSD have improved in Europe 
but the uptake of PsySupp seems not to be adequate. 
PsySupp for parents of children with DSD should be an obligatory part in the 
interdisciplinary care of children and adolescents to reduce fears of stigmatisation by 
psychological counselling and to enable parents to provide their children with good parental 
support. So far, the method, extent and content of PsySupp is be based on the individual 
situation and needs of the parents as yet no special concepts for PsySupp in DSD are 
available. Interdisciplinary teams with psychologically trained medical staff and medically 
trained psychologists are needed to reduce fears and concerns regarding gender issues, 
hormonal treatment and surgery. However, the structure, scope and content of PsySupp for 




Review of the main findings  
The three studies of this cumulative thesis gave evidence-based answers to the research 
questions arising from the research status. 
1. Does the opinion of individuals with conditions classified as DSD about the DSD 
terminology conform with the dissatisfaction expressed by researchers, clinicians and 
support groups and should it be therefore avoided? 
The results of the first study showed, that the majority of participants in the dsd-LIFE cohort 
had a neutral or positive opinion about the term Disorders of Sex Development. The high 
acceptance rate applied to participants from all diagnosis groups. Participants did not show 
a tendency to prefer alternative terms with no pathologizing potential, and, in general, they 
appeared to prefer terms that were specific to their somatic condition over the general 
Disorders of Sex Development designation. Most interestingly, the term intersex which is often 
used by support groups was rated the lowest. The Chicago consensus aimed at eliminating 
stigmatising terminology and to replace it by terms more sensitive to individuals with 
Disorders of Sex Development. The data suggest that this aim was, at least partially, achieved. 
Especially since acceptance rates were the highest in the group of participants with 
conditions that prior to 2006 had been labelled hermaphroditism and pseudo-
hermaphroditism. However, objection rates of 32-38% in CAH, Turner, and Klinefelter 
syndromes and, particularly, of 37-40% in the Netherlands and France should caution 
clinicians and researchers against an uncritical use of the new terminology. Overall, the data 
does not support the view that, in general, the term Disorders of Sex Development is 
insensitive to patients needs and should therefore be abandoned. Nevertheless, in the clinical 
situation it is recommended to evaluate and to be sensitive to patients’ preferences. 
2. How do individuals with different DSD conditions rate their Quality of Life and their 
psychological wellbeing, and how do diagnostic groups differ? 
Study II identified a trend of lowered mental health related Quality of life (HRQoL) and 
significantly higher physical HRQoL for participants as compared to a normative population. 
Group comparison leads to the hypothesis that females with XY DSD might profit from an 
early effect of androgens, thus contributing to positive physical HRQoL. Although there was 
a high physical HRQoL, participants reported significantly impaired psychological well-
being; 42.7% could be described as clinical cases. Impaired psychological well-being is an 
unfortunate outcome in many people with DSD, and it can be concluded, that specialised 




3. Do parents of children with DSD express a need for psychological support and does 
gender and treatment related factors influence this need, so that psychological care for 
parents may focus on specific issues? 
Study III showed that parents of a child with DSD have a high subjective need for 
psychological support, but half of them did not receive it as needed. In particular, a high 
need for psychological support is indicated for parents of children and adolescents with 
partial or mixed gonadal dysgenesis, pAIS and disorder of androgen synthesis (children with 
XY-DSD with androgen effects). In the last decade, the possibility of receiving psychological 
support for families of a child with DSD have improved in Europe but the uptake of 
psychological support seems not to be adequate. For parents of children with DSD getting to 
know the mental health provider should be an obligatory part of the interdisciplinary DSD 
care. This can avoid fears and reservations towards psychological counselling. A low 
threshold psychological support is likely to increase the uptake of the service, which can 
enable parents to provide their children with good parental support. So far, the method, 
extent and content of psychological support is based on the individual situation and the 
parents needs as no special concepts for psychological support in DSD are yet available. 
Interdisciplinary teams with psychologically trained medical staff and medically trained 
mental health professionals are needed to reduce fears and concerns regarding gender issues, 
hormonal treatment and surgery. However, the structure, scope and content of psychological 
support for DSD have to be improved and programmes developed. 
Strength and limitations  
The three presented studies were part of two large quantitative cross-sectional outcome 
studies, network DSD and dsd-LIFE. In network DSD 110 adults and 329 caregivers, in dsd-
LIFE 1040 adults with conditions which are medically labelled as Disorders of Sex 
Development were included. So far, the largest cohort in DSD research. It was therefore 
possible to evaluate the views of individuals by diagnostic group and add more detailed 
empirical data to the current scientific knowledge. In addition to the great size of the cohort 
(given the rareness of DSD), all somatic conditions were medically confirmed, thus securing 
that only participants affected by DSD participated. Therefore, both studies did not need to 
rely solely on information from the participants themselves.11 Furthermore network DSD and 
dsd-LIFE included a diversity of psycho-social patient reported outcomes which was rare in 
DSD research when the studies were designed. Both studies added empiric information in 
DSD research to a high extent.  
Network DSD published 13 original articles: Jürgensen, Hiort, Holterhus, and Thyen (2007); 
Jürgensen et al. (2010); Jürgensen et al. (2013); Jürgensen et al. (2014); Kleinemeier, 
Jürgensen, et al. (2010); Kleinemeier, Jürgensen, et al. (2010); Kleinemeier, Werner-Rosen, 
Jürgensen, and Thyen (2007); Köhler et al. (2012); Lux et al. (2009); Thyen, Lanz, 
 
11 Which, in my experience in dsd-LIFE were unreliable; e.g. in Berlin three participants managed to participate 
in the study after showing medical certificate and were excluded after the medical examination as they did not 
have any DSD condition (two of them had gender dysphoria, one had a disorder of the adrenal gland). 
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Holterhus, and Hiort (2006); Thyen et al. (2014) as well as Bennecke, Thyen, Grüter, Lux, 
and Köhler (2016) and Bennecke et al. (2015) 
So far dsd-LIFE has published 17 original research paper: de Vries et al. (2019); Engels et 
al. (2018); Falhammar et al. (2018); Gehrmann et al. (2019); Kreukels et al. (2019); 
Kreukels et al. (2018); Noordman et al. (2019); Nordenstrom et al. (2018); Nygren, 
Sodersten, Thyen, Kohler, and Nordenskjold (2019); Rapp et al. (2018); Riehl et al. (2019); 
Rohle et al. (2017); Sowikowska-Hilczer et al. (2017); Thyen et al. (2018); van de Grift, 
Cohen-Kettenis, de Vries, Kreukels, and dsd-Life group (2018); van de Grift and Kreukels 
(2019) as well as Bennecke et al. (2020). Further manuscripts are submitted or in 
preparation.  
Although network DSD and dsd-LIFE helped to objectify various discourses in DSD care there 
were significant methodical problems. Both studies emphasised on including almost all areas 
of interests in DSD research satisfying multiple stakeholders’ interests. This plurality of 
questionnaires and single item questions resulted in multiple testing and repeated utilisation 
of outcomes, while other questions could not be included in any evaluation.12 Therefore, 
analyses have an exploratory character and interpretation of statistical characteristics is 
limited. As known, quantitative data of observational studies has limitations in explaining, 
why individuals preferred specific terminology, reported limited or higher quality of life or 
desired psychological support. Various confounding variables could influence associations 
between condition and patient reports. Moreover, selective memories of participants socially 
desirable response behaviour could lead to an information bias. Furthermore,  generalisation 
of the results is limited. Although both studies emphasise on including many participants 
from different backgrounds, a selection bias can be assumed. Reasons are diverse:  
- Most participants were (former) patients of the centres (often paediatric)  
- Recruitment was more successful if there was a good doctor-patient-relationship 
- Not all individuals with DSD are aware of their condition (and its classification as 
DSD, a term introduced 2005). 
- Negative experiences and fears of medicine could have prevented participating.  
- The term DSD and its controversy hindered participation 
- The study required participants to have a conscious look on what was for some 
unpleasant or even traumatising experiences.  
- Questionnaires about sexuality might not have been appropriate for culture or 
religious reasons.  
- Study participation took several hours (with no financial compensation), sometimes 
traveling to the centre and overnight stay was needed.  
Although some of the methodical difficulties might be solved with improved study design, 
most of them are more profound and deal with the subject of the research. The rarity of the 
conditions, especially of some conditions labelled as XY DSD makes enables reliable 
quantitative research extremely difficult. Even though the cohorts of network DSD and dsd-
 
12 Especially parts of the self-constructed questionnaires could not be analysed statically. 
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LIFE are impressive, the DSD classification includes an extreme heterogeneous group of 
conditions, which differ substantially among each other. This results e.g. in different timing 
of diagnoses, different needs for hormonal treatment or surgical procedures. When grouping 
individuals with these different conditions in one group, or subgroup, interindividual 
differences are underestimated and too much emphasis is given on differences to 
comparative groups.  
But even if some participants have the same condition, they are likely to have made very 
different experiences. DSD care, clinical guidelines, medical procedures e.g. surgical 
techniques, thus the experiences of the individuals with DSD, have changed significantly 
within the last decades. Therefore, older individuals received a highly different clinical care 
than families and adolescents nowadays, this also implies changes in decision making and 
education. Moreover, the medical perspective on surgical procedures on genitalia in infancy 
changed considerably and will keep changing furthermore, as changes in children’s rights, 
self-determination and views on sex and gender in society are proceeding. Moreover, DSD 
care is influenced by religious and cultural norms, therefore transferring results from one 
country or subculture to another is problematic. Consequently, identifying condition related 
factors influencing psychological wellbeing and need for psychological support due to 
quantitative research is hardly possible.  
In conclusion, generalisation of the results of the presented studies is limited. Together with 
DSD research in all psychosocial areas the three studies of this thesis showed, that there is a 
great diversity in the needs of individuals with DSD. Empiric research on its own fails to 
identify an evidence-based gold standard for DSD care, therefore guidelines depend on 
clinical expertise and up-to-date ethical considerations. All key documents about DSD care 
agree on the importance of psychological support which was underpinned by the present 
studies. Mental health professionals working with individuals with DSD need to be experts 
of rare medical conditions in order to be able to support affected individuals and their 
families the best possible way. 
Training for mental health professionals 
It becomes evidential, that when offering psychological support in DSD care a profound 
training in DSD is essential. Unfortunately, there are rarely mental health professionals with 
sufficient expertise (Birnbaum et al., 2013). Atypical sex development is complex, even for 
health professionals difficult to understand. A curriculum for psychologists and 
psychotherapists is required (Birnbaum et al., 2013; Richter-Appelt & Schweizer, 2010; 
Schweizer et al., 2009). 
What is DSD? 
Working on the thesis as a psychotherapist I was often confronted with manifold questions 
from colleagues about DSD. On the one hand this confirmed the lack of DSD education in 
mental health professionals, on the other it gave me the opportunity to identify how one 
may explain DSD with a non-stigmatising inclusive approach. I now use this approach in 
psychological counselling for individuals with DSD and their families, in education for 
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students and in the theoretical background of this thesis. This education starts by not using 
terms, that categorizes individuals with DSD as “other” than the addressee of my education. 
Therefore, the term “intersex” is used at a later point. The education includes an explanation 
of typical sex development. By explaining its complexity (that all embryos can develop in a 
typically male or typically female way no matter of the sex chromosomes, that multiple genes 
are needed and that different hormones and enzymes influence the development of the 
anatomic sex, which is the same in all embryos) the addressee might feel a bit overwhelmed 
at first. But the knowledge about the complexity gives the opportunity to come to the 
conclusion, that variations of dichotomous differentiation pathways, thus DSD exist 
naturally. With the biological background given, most DSD conditions can be understood. 
After the typical development, the DSD classification can be introduced and specific DSD 
conditions and their genesis can be presented. In doing so, the focus lies on the frequency of 
all DSD conditions together, rather than on the rarity of specific conditions. The DSD 
classification proposed by the Chicago Consensus Group is helpful, as the classification under 
one umbrella term is an inclusive approach which helps individuals with these rare 
conditions not be exposed as curiosities13, 14. Rather than gender identity, psychological 
wellbeing and quality of life should be in the focus of trainings about DSD care. Conditions 
were there is atypical genitalia most often gain most interests of addressees. When focusing 
on these conditions, other conditions will be outshined, even though they are more frequent 
and do need a similar clinical approach. Reasons for surgeries and other medical treatments 
are diverse and most often in need for complex ethical and medical considerations. A simple 
solution usually does not do justice to the situation. Most often only mental health 
professionals working in interdisciplinary DSD teams take part in such decision making. For 
other mental health professionals discussing medical treatments in DSD, especially surgeries 
in childhood, is most often not of clinical, but of political interest. Even if these political 
considerations are important, they often simplify the situation families and individuals with 
DSD are facing. Therefore, training in DSD includes an education about the limited 
knowledge of the addressee.  
Psychological support  
During the period of time when individuals receive their diagnose and when medical 
interventions are needed, optimal psychological support for individuals with DSD, requires 
an understanding of treatment choices. This is only possible in interdisciplinary teams with 
a close collaboration between mental health professional and medical professionals. Only 
with profound knowledge mental health professionals will be able to fulfil the expectations 
 
13 It can be assumed that excluding conditions such as Turner syndrome, Klinefelter syndrome and CAH is 
motivated by the desire not to link these conditions to other rare conditions that are stigmatised. 
14 Although the DSD classification as an umbrella term is helpful for education, in clinical context terminology 
should be individualised. By contrasting that it is not a “disease” one female with CAIS insisted on having a 
„disorder“. Another female with the medical diagnose Turner syndrome demanded that her condition should not 
be named Turner syndrome as she had a chromosomal mosaic and she didn’t want to be associated with 
representations and images of individuals with Turner syndrome in textbooks and the internet.  
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of psychological support that was included in the statements of the Chicago Consensus Group 
and the German Ethical Committee; 
- Monitoring of the diagnoses and the mediation of treatment proposals 
- Education on the most frequent consequences of the DSD, e.g. reproductive capacity, 
intimate contacts, behavioural problems, adaptation problems;  
- Supporting all stakeholders in stress situations and anticipating feelings such as shame, 
guilt, stigma;  
- Support for coping strategies and communication with third parties about the condition;  
- Strengthening family resources;  
- Evaluation of gender identity, in order to help in the case of decision-making processes;  
- Transition: transfer of young adults into adult medicine (gynaecology, internal 
medicine, psychology);  
- Structured documentation of long-term monitoring;  
- Mediation of contacts with psychotherapists and sexologists living near the place of 
residence, with other persons concerned (with their written consent) and self-help 
groups (Birnbaum et al., 2013). 
This integrative mental health approach differs from the traditional role of a mental health 
provider – who would be consulted only when psychiatric problems are suspected (Sandberg 
& Mazur, 2014).  
In addition to the interdisciplinary DSD team mental health professionals can be involved in 
the care of individuals with DSD in different situations. Apart from psychological issues such 
as coping, shame, communication and compliance, which might be relevant in other 
chronicle somatic conditions as well, individuals with DSD have some special psychological 
topics. In the following the main areas of concerns of adolescents and adults with DSD will 
be described. On the one hand these are contexts when mental health professionals not 
working in an interdisciplinary DSD team get in touch with individuals with DSD, on the 
other these are areas where there is need for special training of mental health professionals. 
These topics are mentioned in most research and recommendations about DSD care and 
were - next to general topics - the most frequent issues I was confronted with in my clinical 
experience with over a hundred individuals with DSD. To outline areas of training for mental 
health professionals, these topics will be hinted below. 
Traumatisation due to medical treatment 
In most DSD conditions hormonal treatment is needed, therefore the majority of individuals 
with DSD had or have some kind of medical treatment. Especially individuals with CAH or 
XY DSD conditions may have had multiple contacts to different medical experts and often 
genitalia surgery or gonadal removal were performed. Particularly if treated according to 
former guidelines these individuals were often not well informed about the procedures and 
sometime were told lies about their condition. Some were asked to show their private parts 
frequently, not just for medical reason, but for education of medical students. Such 
experiences can be traumatising and discriminating. Under these circumstances, individuals 
with DSD may have lost their trust in medical and psychological care and might be sceptical 
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or anxious and have difficulties in utilisation of medical and psychosocial services. Therefore, 
mental health professionals should be trained in recognising symptoms of traumatisation, 
even though there is high psychological functioning in most individuals with DSD. In order 
to be prepared for potentially shocking case reports, mental health professionals should also 
be aware of former treatments. They should also keep in mind, that experiences are 
subjective and that dealing with negative experiences does not always mean to clarify the 
past. 
Infertility  
In most DSD conditions, other that CAH, there is infertility and some DSD conditions (like 
Klinefelter Syndrome) are often diagnosed in a fertility clinic. In some conditions, there 
might be the opportunity for fertility treatment such as sperm donation or in vitro 
fertilisation, but most often individuals with DSD are not able to have their own biological 
children. Infertility is relevant for parents of children with DSD and the affected individual 
in different stages of life, not only at the age of a realistic desire to have children. Individuals 
with DSD may hope that they will get their own children in the future, when treatment 
options improve.15 Adoption could be an alternative for some individuals with DSD but is 
not necessarily realistic for all. Infertility might also impact (desired) partnership and could 
isolate individuals with DSD from their peers. Mental health professionals counselling 
individuals with DSD should be aware of the somatic condition and the chances for fertility 
in order to help individuals with DSD to cope with their infertility.  
Gender 
In their identity development, some individuals with DSD are questioning their gender 
identity. Given the incongruence of the somatic sex, it can be a challenge to discover their 
own gender identity for some individuals with DSD, which may not be male or female. If this 
affects children, not only the child but also the family and the environment are affected. 
Sometimes a gender change is needed. This is especially complex if individuals had genital 
surgery and feel gender incongruence later in life. Mental health professionals in DSD care 
should be aware of different non-normative pathways of gender development; therefore, 
reflection of the own gender and of gender in society is needed. Experiences with individuals 
having gender dysphoria may be helpful in order to counsel and support individuals with 
DSD appropriately. Most often individuals with DSD do not suffer from gender dysphoria, 
but often the condition has an impact on ones gender identity in a more holistic sense: “What 
kind of men am I, if I need testosterone injections/ …when I can’t use the urinal”, “What 
kind of a women am I, if I cannot have children/ …if I have an enlarged clitoris/…if I have 
XY chromosomes”. Such questions of life can be very significant for the affected individuals, 
but as well for their caregivers.  
 
15 E.g. Uterus transplantation 
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Partnership and sexuality 
The conglomerate of condition related factors, concealment in communication, bad 
experiences in medical treatment, infertility and gender problems can affect partnership and 
sexuality in many ways. Sexual dysfunction may arise from former surgery or is related to 
the condition, e.g. when the vaginal entrance is very narrow. Also, insufficient hormonal 
treatment can result in a lack of sexual desire, erectile dysfunction or lack of lubrication. An 
interdisciplinary approach including endocrinology, gynaecology/ urology and surgery may 
be necessary. However, these issues can as well be psychosomatic. Mental health 
professionals therefore should be able to talk openly about sexuality, at best they have 
training in sex and couple therapy. Similar to the approach in dealing with gender, mental 
health professionals should reflect non-normative ways of sexuality and sexual orientation. 
This is especially relevant in counselling adolescents, as sexuality, attraction to others and 
partnership are new and exciting, but also challenging areas in this age group.  
Education 
Especially in psychological counselling in the time of diagnosis, education about the 
condition is crucial. If mental health professionals counsel parents with children with DSD 
or affected individuals, they have to have a sufficient expertise about the condition, in order 
to be able to inform without confusing individuals seeking for help. Also, individuals with 
DSD may need education about their condition later in life, because they either may have 
forgotten information or might not have been educated appropriately in the past. If 
compliance to important medical treatments is missing, education about the consequences 
is important. Mental health professionals should be aware of sex hormonal influencing 
psychosocial wellbeing, health risks such as osteoporosis if sex hormones are missing or 
mortal danger if cortisol treatment is suspended. They then should refer to a medical 
practitioner or should talk about potential fears hindering patients to consult medical 
practitioner. Beside the education of individuals with DSD, health professionals with 
expertise could be contact person for other people caring for the individuals with DSD – e.g. 
the general practitioner, the psychotherapist, teachers, social workers, partners or family 
members.  
General Conclusion 
Network DSD and dsd-LIFE were two extraordinary research studies adding needed empiric 
information to existing DSD research. This thesis compromises three sub studies about 
psychosocial aspects; The view of individuals with DSD on the term Disorders of Sex 
Development, health-related quality of Life and psychological wellbeing of adults with DSD 
and the subjective need for psychological support in parents of children and adolescents with 
DSD. Next to the empirical results, strength and limitations of the studies were discussed. It 
was concluded, that empiric research on its own fails to identify an evidence-based gold 
standard for DSD care. Therefore, DSD guidelines depend on clinical expertise and ethical 
considerations. As problem areas of individuals with DSD vary, mental health professionals 
need a training when offering the best psychological support. The extent of specialised 
training in DSD for mental health professionals depends on the part they have in clinical 
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DSD care; supporting families at the time of diagnosis and in times of decision making 
requires the most comprehensive knowledge. These mental health professionals should work 
in an interdisciplinary DSD team, which includes experts in endocrinology, ethics, genetics, 
surgery, paediatrics, urology and gynaecology16. Training for mental health professionals 
should be broad, as needs and problem areas of individuals are diverse. It should include 
biological basics, information about chronic health conditions and medical treatments. It 
should incorporate education about mental disorders, gender, ethics and sexuality. 
Moreover, mental health professionals should be trained in working with children, 
adolescents and adults and additionally ought to be able to work in individual setting, but 
as well feel comfortable in working with parents, families and couples. 
Members of the two research teams from network DSD and dsd-LIFE presented their work 
over the years countless times in different national and international conferences, gave 
lectures and poster presentations. That way they not only added empirical data but 
communicated up to date knowledge to a wide public and taught their audience about DSD. 
In addition, all members of the studies got educated in DSD themselves while researching, 
in conferences and at meeting with support groups. In addition, all team members who were 
involved in the data collection were able to learn from experts and their own experience. 
Since the studies emphasised on involving mental health professionals, over thousand 
participating individuals with DSD received psychological support or were at least enabled 
to get in touch with a mental health professional with expertise in DSD.  
I therefore conclude that network DSD, dsd-LIFE and this thesis addressed the request for 
research studies focusing on psychological and social aspects and contributed to a better 
psychological support of persons with DSD and their families. Moreover, the presented 
cumulative thesis outlined the basis for implementing DSD care in education programmes 
for mental health professionals as it was required inter alia by the German Ethical 
Committee. 
 








The typical prenatal male or female development of the somatic sex is a complex 
differentiation process affected by multiple genes, enzymes and hormones. Conditions in 
which the development of the somatic sex is atypical are medically summarised under the 
umbrella term “Disorders of Sex Development“ (DSD). Although new clinical guidelines 
emphasize the importance of psychosocial care, there is a research gap, since most research 
studies focus on medical aspects rather than on psychological or social aspects. The aim of 
the present cumulative thesis is to close this research gap with a quantitative study design 
based on patient reported outcomes.  
The three studies in this thesis were part of two large quantitative cross-sectional outcome 
studies, network DSD and dsd-LIFE. So far, these two studies have the largest cohorts in DSD 
research. Furthermore, network DSD and dsd-LIFE included a diversity of psycho-social 
outcomes, which was rare in DSD research when the studies were designed. It was therefore 
possible to evaluate the views of individuals by diagnostic group and add more detailed 
empirical data to the current scientific knowledge.  
The first evaluation focused on the term Disorders of Sex Development (DSD) invented in 
2005 by the „Chicago Consensus Group on management of intersex conditions“ - an 
international congress of experts. The DSD terminology is controversial, as dissatisfaction 
about it was expressed by researchers, clinicians and support groups. It is stated that it should 
therefore be avoided. The European research group dsd-LIFE evaluated opinions on the 
terminology from 1040 individuals with conditions labelled as Disorders of Sex Development. 
Overall, a large majority of participants (69%) reported that the term Disorders of Sex 
Development applies to their condition or that they feel neutral about it. Overall, the data 
does not support the view that, in general, the term Disorders of Sex Development is 
insensitive to concerns of affected persons and that it should therefore be abandoned. 
In the second study, health related Quality of life (HRQoL) and psychological wellbeing of 
individuals with DSD were evaluated as indicators of successful psychosocial adaptation to 
the conditions. 110 adults with DSD from the multicentre clinical evaluation study of the 
German network DSD were included. A trend towards a lower mental HRQoL and a 
significantly higher physical HRQoL of the participants compared to a norm was found. 
Participants reported significant higher psychological distress compared to the norm. Forty-
seven participants (43%) reported distress in a clinically relevant range. This outcome 
supports the demand for psychological support in DSD care. 
In the third study the subjective need for psychological support in parents of children and 
adolescents with DSD was analysed. 329 parents of children with DSD who took part in the 
multicentre clinical evaluation study of the German network DSD were included. 40% of the 
parents indicated to have a need for psychological support, only 50% of this group received 
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it adequately. In particular, parents of children with XY-DSD with androgen effects other 
than hypospadias expressed a high need for psychological support. Psychological support 
therefore should be improved and should be an integral part of DSD care with families with 
children and adolescents with DSD. 
Although network DSD and dsd-LIFE helped to objectify the discourse about the DSD 
terminology and support the demand of psychosocial support in DSD care there were 
significant methodical problems. In summary, the results of the studies presented can only 
be generalised to a limited extent. Together with DSD research in all psychosocial areas, the 
three studies of this thesis showed, that there is a great diversity in the needs of individuals 
with DSD. Empirical research alone cannot establish an evidence-based gold standard for 
DSD care, therefore guidelines depend on clinical expertise and current ethical 
considerations. In summary, training of mental health professionals is needed and training 
should cover clinically relevant topics such as traumatisation, infertility, gender, partnership, 





Die pränatale Entwicklung des somatischen Geschlechts ist ein komplexer 
Differenzierungsprozess verschiedener Organe, der von unterschiedlichen Genen, Enzymen 
und Hormonen beeinflusst wird. Körperliche Entwicklungen, bei denen diese 
Differenzierung untypisch verläuft, werden in der Medizin unter dem Überbegriff 
„Varianzen/ Störungen der Geschlechtsentwicklung“ (engl. Disorders of Sex Development, 
kurz DSD) zusammengefasst. Die meisten Menschen mit DSD benötigen irgendwann in 
ihrem Leben medizinische Versorgung. Aktuelle klinische Leitlinien betonen aber 
zunehmend auch die Notwendigkeit psychologischer Unterstützung für diese Menschen und 
ihre Familien. Der Fokus wissenschaftlicher Forschung liegt hingegen auf medizinischen und 
nicht auf psycho-sozialen Aspekten, wodurch eine Forschungslücke entstanden ist und wenig 
empirisch belastbare Untersuchungen zu psychosozialen Aspekten bei Menschen mit DSD 
vorliegen. Diese Forschungslücke soll mit der vorliegenden kumulativen Arbeit geschlossen 
werden.  
Die drei Studien der kumulativen Arbeit sind Teilstudien zweier großer quantitativer 
Querschnittsstudien, dem Netzwerk DSD und der europäischen Studie dsd-LIFE. Zwei der 
bisher größten DSD Studien, die durch ihre großen Stichproben (angesichts der Seltenheit 
von DSD) Analysen zwischen Untergruppen erlaubten und detailliertere empirische Daten 
zu dem aktuellen Wissensstand ergänzen konnten.  
Die erste Teilstudie fokussiert auf den Begriff Störung der Geschlechtsentwicklung (DSD), der 
2005 von der „Chicago Consensus Group on management of intersex conditions“ einem 
internationalen Komitee mit Expertise vorgestellt wurde. Dieser Begriff wird kontrovers 
diskutiert und teilweise stark abgelehnt. Die Forschungsfrage war, ob dies auch die Meinung 
von Menschen mit körperlichen Entwicklungen, die als DSD klassifiziert werden, ist und 
daraus folgend, der Begriff daher vermieden werden sollte. Die Meinungen von 1040 
Teilnehmenden der europäischen dsd-LIFE Studie wurden analysiert. Die Mehrheit (69%) 
gab an, dass sie den Begriff für sich als passend empfindet oder ihm neutral gegenüber steht. 
Zusammenfassend zeigen die empirischen Daten nicht, dass die Mehrheit der Menschen mit 
DSD sich von dem DSD Begriff angegriffen fühlt und die Verwendung daher grundsätzlich 
eingestellt werden sollte.  
In der zweiten Studie wurden gesundheitsbezogene Lebensqualität und psychisches 
Wohlbefinden von 110 Menschen mit DSD, die an der Studie des Netzwerk DSD teilnahmen, 
analysiert. Die Teilnehmenden berichteten von einer besseren körperlichen Lebensqualität 
als die Norm, während die psychische Belastung höher war. Insgesamt erreichten 43% der 
Teilnehmenden psychische Belastungswerte innerhalb eines klinisch relevanten Bereichs. 
Diese Ergebnisse untermauern die Forderung nach psychologischer Unterstützung bei der 
Versorgung von Menschen mit DSD.  
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Die dritte Studie geht der Frage nach, inwieweit Eltern von Kindern oder Jugendlichen mit 
DSD einen Bedarf nach psychologischer Unterstützung äußern. Antworten von 329 Eltern, 
die an der Studie des Netzwerk DSD teilnahmen wurden analysiert. 40% der Eltern äußerten 
einen Wunsch nach psychologischer Unterstützung, wobei nur 50% dieser Eltern angaben, 
diese Versorgung hinreichend erhalten zu haben. Besonders Eltern von Kindern mit XY-DSD 
mit partiellem Androgeneffekt äußerten einen hohen Bedarf an psychologischer 
Unterstützung.  
Das Netzwerk DSD und dsd-Life waren in der Lage, die Diskurse in der DSD Versorgung zu 
objektivieren und untermauern die Forderung nach psychologischer Unterstützung. 
Dennoch gibt es methodische Schwierigkeiten, die die Generalisierbarkeit der Ergebnisse 
eingeschränken. Die drei Studien dieser Arbeit zeigten, dass es eine große Diversität in den 
Bedürfnissen von Menschen mit DSD gibt. Um die bestmöglichen Leitlinien für DSD 
Versorgung zu definieren, reicht wissenschaftliche Forschung allein daher nicht aus. Auch 
klinische Expertise und aktuelle ethische Überlegungen müssen berücksichtigt werden. Um 
eine hinreichende psychologische Versorgung zu gewährleisten, erscheinen Schulungen von 
psychologischem Personal unerlässlich. Eine solche Schulung sollte Themen wie 
Traumatisierungen, Unfruchtbarkeit, Geschlecht, Partnerschaft, Sexualität und Aufklärung 
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